q3fy08.htm
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
10-Q
(Mark
One)
x
|
QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
1934
|
For
the quarterly period ended March 30, 2008
or
o
|
TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
1934
|
|
For
the transition period from
|
|
to
|
|
Commission
File Number 0-14864
LINEAR
TECHNOLOGY CORPORATION
(Exact
name of registrant as specified in its charter)
DELAWARE
|
|
94-2778785
|
(State
or other jurisdiction of
|
|
(I.R.S.
Employer Identification No.)
|
incorporation
or organization)
|
|
|
|
|
|
1630 McCarthy Boulevard, Milpitas,
California
|
|
95035
|
(Address
of principal executive offices)
|
|
(Zip
Code)
|
(408)
432-1900
(Registrant’s
telephone number, including area code)
N/A
(Former
name, former address and former fiscal year, if changed since last
report)
Indicate
by check mark whether the registrant (1) has filed all reports required to be
filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the
preceding 12 months (or for such shorter period that the registrant was required
to file such reports), and (2) has been subject to such filing requirements for
the past 90 days.
Indicate
by check mark whether the registrant is a large accelerated filer, an
accelerated filer, or a non-accelerated filer. See definition of
“accelerated filer and large accelerated filer” in Rule 12b-2 of the Exchange
Act.
Large
accelerated filer x
|
Accelerated
filer o
|
Non-accelerated
filer o
|
Indicate
by check mark whether the registrant is a shell company (as defined in Rule
12b-2 of the Exchange Act).
Shares
outstanding of the Registrant’s common stock:
Class
|
|
Outstanding
at April 25, 2008
|
Common
Stock, $0.001 par value per share
|
|
221,863,484
shares
|
LINEAR
TECHNOLOGY CORPORATION
FORM
10-Q
THREE
AND NINE MONTHS ENDED MARCH 30, 2008
INDEX
|
|
|
Page
|
Part
I:
|
Financial
Information
|
|
|
|
|
|
|
Item
1.
|
Financial
Statements
|
|
|
|
|
|
|
|
|
|
|
|
ended
March 30, 2008 and April 1, 2007
|
3
|
|
|
|
|
|
|
|
4
|
|
|
|
|
|
|
|
|
|
|
March
30, 2008 and April 1, 2007
|
5
|
|
|
|
|
|
|
|
6-12
|
|
|
|
|
|
Item
2.
|
|
|
|
|
Results
of Operations
|
13-17
|
|
|
|
|
|
Item
3.
|
Quantitative
and Qualitative Disclosures About Market Risk
|
18
|
|
|
|
|
|
Item
4.
|
Controls
and Procedures
|
18
|
|
|
|
|
Part
II:
|
Other
Information
|
|
|
|
|
|
|
Item
1.
|
Legal
Proceedings
|
18-20
|
|
|
|
|
|
Item
1A.
|
Risk
Factors
|
20-25
|
|
|
|
|
|
Item
2.
|
Unregistered
Sales of Equity Securities and Use of Proceeds
|
26
|
|
|
|
|
|
Item
6.
|
Exhibits
|
27
|
|
|
|
|
|
|
|
|
Signatures:
|
|
28
|
|
|
|
|
|
|
|
|
PART
I. FINANCIAL
INFORMATION
Item
1. Financial
Statements
LINEAR
TECHNOLOGY CORPORATION
(In
thousands, except per share amounts)
(unaudited)
|
Three
Months Ended
|
|
Nine
Months Ended
|
|
March
30,
|
|
April
1,
|
|
March
30,
|
|
April
1,
|
|
2008
|
|
2007
|
|
2008
|
|
2007
|
Revenues
|
$ 297,865
|
|
$ 254,992
|
|
$ 868,073
|
|
$ 814,962
|
Cost
of sales (1)
|
66,939
|
|
56,535
|
|
197,212
|
|
180,175
|
Gross
profit
|
230,926
|
|
198,457
|
|
670,861
|
|
634,787
|
|
|
|
|
|
|
|
|
Expenses:
|
|
|
|
|
|
|
|
Research and development (1)
|
49,613
|
|
45,364
|
|
145,192
|
|
136,844
|
Selling, general and
administrative (1)
|
35,423
|
|
32,807
|
|
101,761
|
|
100,829
|
|
85,036
|
|
78,171
|
|
246,953
|
|
237,673
|
|
|
|
|
|
|
|
|
Operating
income
|
145,890
|
|
120,286
|
|
423,908
|
|
397,114
|
Interest
expense
|
(14,435)
|
|
(422)
|
|
(43,371)
|
|
(1,298)
|
Interest
income
|
7,334
|
|
17,011
|
|
21,026
|
|
49,791
|
|
|
|
|
|
|
|
|
Income before income
taxes
|
138,789
|
|
136,875
|
|
401,563
|
|
445,607
|
Provision
for income taxes
|
39,555
|
|
38,325
|
|
117,099
|
|
129,656
|
|
|
|
|
|
|
|
|
Net income
|
$ 99,234
|
|
$ 98,550
|
|
$ 284,464
|
|
$ 315,951
|
|
|
|
|
|
|
|
|
Basic
earnings per share
|
$ 0.45
|
|
$ 0.33
|
|
$ 1.28
|
|
$ 1.05
|
Shares
used in the calculation of basic
|
|
|
|
|
|
|
|
earnings
per share
|
222,046
|
|
299,455
|
|
221,979
|
|
300,212
|
|
|
|
|
|
|
|
|
Diluted
earnings per share
|
$ 0.44
|
|
$ 0.32
|
|
$ 1.26
|
|
$ 1.03
|
Shares
used in the calculation of diluted
|
|
|
|
|
|
|
|
earnings
per share
|
224,489
|
|
304,640
|
|
225,842
|
|
305,677
|
|
|
|
|
|
|
|
|
Cash
dividends per share
|
$ 0.21
|
|
$ 0.18
|
|
$ 0.57
|
|
$ 0.48
|
|
|
|
|
|
|
|
|
(1) Includes stock-based
compensation charges as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of sales
|
$ 1,996
|
|
$ 2,933
|
|
$ 5,865
|
|
$ 8,535
|
Research and
development
|
8,360
|
|
9,563
|
|
24,289
|
|
27,746
|
Selling, general and
administrative
|
4,675
|
|
5,839
|
|
13,503
|
|
16,901
|
|
|
|
|
|
|
|
|
See
accompanying notes
LINEAR
TECHNOLOGY CORPORATION
(In
thousands, except par value)
|
|
|
|
|
|
|
|
|
March
30,
|
|
|
July
1,
|
|
|
|
2008
|
|
|
2007
|
|
|
|
(unaudited)
|
|
|
|
|
|
Assets
|
|
|
|
|
|
|
|
Current
assets:
|
|
|
|
|
|
|
|
Cash and cash
equivalents
|
|
$ |
119,177 |
|
|
$ |
156,494 |
|
Short-term
investments
|
|
|
788,762 |
|
|
|
476,813 |
|
Accounts
receivable, net of allowance for
|
|
|
|
|
|
|
|
|
doubtful accounts of $1,759
($1,775 at July 1, 2007)
|
|
|
150,233 |
|
|
|
130,546 |
|
Inventories:
|
|
|
|
|
|
|
|
|
Raw materials
|
|
|
4,777 |
|
|
|
4,318 |
|
Work-in-process
|
|
|
38,919 |
|
|
|
35,002 |
|
Finished goods
|
|
|
10,679 |
|
|
|
11,755 |
|
Total
inventories
|
|
|
54,375 |
|
|
|
51,075 |
|
Deferred tax
assets
|
|
|
32,442 |
|
|
|
35,038 |
|
Prepaid expenses and other
current assets
|
|
|
16,443 |
|
|
|
11,138 |
|
Total current
assets
|
|
|
1,161,432 |
|
|
|
861,104 |
|
Property,
plant and equipment, at cost:
|
|
|
|
|
|
|
|
|
Land, buildings and
improvements
|
|
|
205,225 |
|
|
|
201,547 |
|
Manufacturing and test
equipment
|
|
|
461,016 |
|
|
|
449,175 |
|
Office furniture and
equipment
|
|
|
3,400 |
|
|
|
3,332 |
|
|
|
|
669,641 |
|
|
|
654,054 |
|
Accumulated depreciation and
amortization
|
|
|
(418,154 |
) |
|
|
(387,454 |
) |
Property,
plant and equipment, net
|
|
|
251,487 |
|
|
|
266,600 |
|
Other
non current assets
|
|
|
90,738 |
|
|
|
91,153 |
|
Total assets
|
|
$ |
1,503,657 |
|
|
$ |
1,218,857 |
|
|
|
|
|
|
|
|
|
|
Liabilities
and stockholders’ deficit
|
|
|
|
|
|
|
|
|
Current
liabilities:
|
|
|
|
|
|
|
|
|
Accounts
payable
|
|
$ |
12,616 |
|
|
$ |
11,161 |
|
Accrued payroll and related
benefits
|
|
|
46,458 |
|
|
|
54,470 |
|
Deferred income on shipments to
distributors
|
|
|
37,672 |
|
|
|
39,946 |
|
Income taxes
payable
|
|
|
20,205 |
|
|
|
45,327 |
|
Other accrued
liabilities
|
|
|
40,609 |
|
|
|
28,965 |
|
Total current
liabilities
|
|
|
157,560 |
|
|
|
179,869 |
|
Deferred
tax liabilities
|
|
|
35,343 |
|
|
|
12,917 |
|
Convertible
senior notes
|
|
|
1,700,000 |
|
|
|
1,700,000 |
|
Other
long-term liabilities
|
|
|
98,326 |
|
|
|
34,036 |
|
Total
liabilities
|
|
|
1,991,229 |
|
|
|
1,926,822 |
|
Commitments
and contingencies
|
|
|
|
|
|
|
|
|
Stockholders’
equity:
|
|
|
|
|
|
|
|
|
Preferred stock, $0.001 par
value, 2,000 shares authorized,
|
|
|
|
|
|
|
|
|
none issued or
outstanding
|
|
|
- |
|
|
|
- |
|
Common stock, $0.001 par value, 2,000,000 shares
authorized,
|
|
|
|
|
|
|
|
|
221,138
shares issued and outstanding at March 30, 2008
|
|
|
|
|
|
|
|
|
(229,655
shares at July 1, 2007)
|
|
|
221 |
|
|
|
229 |
|
Additional paid-in capital
|
|
|
1,006,818 |
|
|
|
901,906 |
|
Accumulated other comprehensive
income, net of tax
|
|
|
4,357 |
|
|
|
(647 |
) |
Accumulated
deficit
|
|
|
(1,498,968 |
) |
|
|
(1,609,453 |
) |
Total stockholders’
deficit
|
|
|
(487,572 |
) |
|
|
(707,965 |
) |
Total liabilities and
stockholders’ deficit
|
|
$ |
1,503,657 |
|
|
$ |
1,218,857 |
|
(1)
Derived from audited financial statements at July 1, 2007
See
accompanying notes
LINEAR
TECHNOLOGY CORPORATION
(In
thousands)
(unaudited)
|
|
Nine
Months Ended
|
|
|
|
March
30,
|
|
|
April
1,
|
|
|
|
2008
|
|
|
2007
|
|
Cash
flow from operating activities:
|
|
|
|
|
|
|
Net
income
|
|
$ |
284,464 |
|
|
$ |
315,951 |
|
Adjustments
to reconcile net income to
|
|
|
|
|
|
|
|
|
net cash provided by operating
activities:
|
|
|
|
|
|
|
|
|
Depreciation and
amortization
|
|
|
36,352 |
|
|
|
38,279 |
|
Tax benefit received on the
exercise of
|
|
|
|
|
|
|
|
|
stock-based
awards
|
|
|
7,206 |
|
|
|
4,595 |
|
Stock-based
compensation
|
|
|
43,657 |
|
|
|
53,182 |
|
Change
in operating assets and liabilities:
|
|
|
|
|
|
|
|
|
(Increase) decrease in accounts
receivable
|
|
|
(19,687 |
) |
|
|
12,052 |
|
Increase in
inventories
|
|
|
(3,300 |
) |
|
|
(11,712 |
) |
Increase in prepaid expenses,
other
|
|
|
|
|
|
|
|
|
current assets and deferred tax
assets
|
|
|
(3,260 |
) |
|
|
(6,312 |
) |
Increase in long-term
assets
|
|
|
(1,084 |
) |
|
|
(5,492 |
) |
Increase (decrease) in accounts payable,
|
|
|
|
|
|
|
|
|
accrued payroll and other
accrued liabilities
|
|
|
566 |
|
|
|
(39,639 |
) |
Decrease in deferred income
on
|
|
|
|
|
|
|
|
|
shipments to
distributors
|
|
|
(2,274 |
) |
|
|
(5,711 |
) |
Increase (decrease) in income
taxes payable
|
|
|
56,098 |
|
|
|
(18,618 |
) |
Increase in long term liabilities
|
|
|
1,033 |
|
|
|
- |
|
Cash
provided by operating activities
|
|
|
399,771 |
|
|
|
336,575 |
|
|
|
|
|
|
|
|
|
|
Cash
flow from investing activities:
|
|
|
|
|
|
|
|
|
Purchase of long-term
investment
|
|
|
(980 |
) |
|
|
- |
|
Purchase of short-term
investments
|
|
|
(858,459 |
) |
|
|
(1,078,932 |
) |
Proceeds from sales and
maturities of
|
|
|
|
|
|
|
|
|
short-term
investments
|
|
|
554,451 |
|
|
|
876,323 |
|
Purchase of property, plant and
equipment
|
|
|
(15,722 |
) |
|
|
(49,090 |
) |
Cash
used in investing activities
|
|
|
(320,710 |
) |
|
|
(251,699 |
) |
|
|
|
|
|
|
|
|
|
Cash
flow from financing activities:
|
|
|
|
|
|
|
|
|
Excess
tax benefit received on exercise of
|
|
|
|
|
|
|
|
|
stock-based
awards
|
|
|
10,686 |
|
|
|
7,721 |
|
Issuance
of common stock under employee
|
|
|
|
|
|
|
|
|
stock plans
|
|
|
52,683 |
|
|
|
42,641 |
|
Purchase
of common stock
|
|
|
(50,704 |
) |
|
|
(209,963 |
) |
Payment
of cash dividends
|
|
|
(129,043 |
) |
|
|
(146,062 |
) |
Cash used in financing
activities
|
|
|
(116,378 |
) |
|
|
(305,663 |
) |
|
|
|
|
|
|
|
|
|
Decrease
in cash and cash equivalents
|
|
|
(37,317 |
) |
|
|
(220,787 |
) |
|
|
|
|
|
|
|
|
|
Cash
and cash equivalents, beginning of period
|
|
|
156,494 |
|
|
|
541,060 |
|
Cash
and cash equivalents, end of period
|
|
$ |
119,177 |
|
|
$ |
320,273 |
|
See
accompanying notes
LINEAR
TECHNOLOGY CORPORATION
(Unaudited)
|
Interim
financial statements and information are unaudited; however, in the
opinion of management, all adjustments necessary for a fair and accurate
presentation of the interim results have been made. All such
adjustments were of a normal recurring nature. The results for
the three and nine month periods ended March 30, 2008 are not necessarily
an indication of results to be expected for the entire fiscal
year. All information reported in this Form 10-Q should be read
in conjunction with the Company’s annual consolidated financial statements
for the fiscal year ended July 1, 2007 included in the Company’s Annual
Report on Form 10-K. The accompanying balance sheet at July 1,
2007 has been derived from audited financial statements as of that
date. Because the Company is viewed as a single operating
segment for management purposes, no segment information has been
disclosed.
|
Revenue
Recognition
The
Company recognizes revenues when the earnings process is complete, when
persuasive evidence of an arrangement exists, the product has been delivered,
the price is fixed and determinable and collection is reasonably
assured. The Company recognizes approximately 16% of net revenues
from North American (“domestic”) distributors that are recognized under
agreements which provide for certain sales price rebates and limited product
return privileges. Given the uncertainties associated with the levels
of pricing rebates, the ultimate sales price on domestic distributor sales
transactions is not fixed or determinable until domestic distributors sell the
merchandise to the end-user. Domestic distributor agreements permit
the following: price protection on certain domestic distribution inventory if
the Company lowers the prices of its products; exchanges up to 3% of certain
purchases on a quarterly basis; and Ship and Debit transactions. Ship
and Debit transactions are transactions in which during the course of securing
business, domestic distributors request the Company to reduce its selling price
on a specific quantity of product in order to complete a particular sales
transaction. When the Company agrees, it rebates to the requesting
distributor, through the acceptance of the distributor’s debit memo, the amount
of the price reduction so negotiated.
At the time of shipment to domestic
distributors, the Company records a trade receivable and deferred revenue at the
distributor purchasing price since there is a legally enforceable obligation
from the distributor to pay for the products delivered. The Company relieves
inventory as title has passed to the distributor and recognizes deferred cost of
sales in the same amount. “Deferred income on shipments to distributors”
represents the difference between deferred revenue and deferred costs of sales
and is recognized as a current liability until such time as the distributor
confirms a final sale to its end customer. “Deferred income on
shipments to distributors” effectively represents the deferred gross margin on
the sale to the distributor, however, the actual amount of gross margin the
Company ultimately recognizes in future periods may be less than the originally
recorded amount as a result of price protection, negotiated price rebates and
exchanges as mentioned above. The wide range and variability of negotiated
price rebates granted to distributors does not allow the Company to accurately
estimate the portion of the balance in the “Deferred income on shipments to
distributors” that will be remitted back to the distributors. These price
rebates that have been remitted back to distributors have ranged from $1.5
million to $3.1 million per quarter. The Company does not reduce deferred income
by anticipated future price rebates. Instead, price rebates are recorded
against “Deferred income on shipments to distributors” when incurred, which is
generally at the time the distributor sells the product.
The Company’s sales to international
distributors are made under agreements which permit limited stock return
privileges but not sales price rebates. The agreements generally
permit distributors to exchange up to 5% of purchases on a semi-annual
basis. Revenue on international distributor sales is recognized upon
shipment at which time title passes. The Company estimates
international distributor returns based on historical data and current business
expectations and defers a portion of international distributor sales and costs
based on these estimated returns.
2.
|
The
Company operates on a 52/53-week year, ending on the Sunday nearest June
30. Fiscal years 2008 and 2007 are 52-week
years.
|
3.
|
Basic
earnings per share is calculated using the weighted average shares of
common stock outstanding during the period. Diluted earnings
per share is calculated using the weighted average shares of common stock
outstanding, plus the dilutive effect of stock options and restricted
stock calculated using the treasury stock method. The following
table sets forth the reconciliation of weighted average common shares
outstanding used in the computation of basic and diluted earnings per
share:
|
|
|
Three
Months Ended
|
|
|
Nine
Months Ended
|
|
In
thousands, except per share
|
|
March
30,
|
|
|
April
1,
|
|
|
March
30,
|
|
|
April
1,
|
|
amounts
|
|
2008
|
|
|
2007
|
|
|
2008
|
|
|
2007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Numerator
- Net income
|
|
$ |
99,234 |
|
|
$ |
98,550 |
|
|
$ |
284,464 |
|
|
$ |
315,951 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Denominator
for basic earnings
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
per
share- weighted
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
average
shares
|
|
|
222,046 |
|
|
|
299,455 |
|
|
|
221,979 |
|
|
|
300,212 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effect
of dilutive securities –
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
employee
stock options and
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
restricted
stock
|
|
|
2,443 |
|
|
|
5,185 |
|
|
|
3,863 |
|
|
|
5,465 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Denominator
for diluted earnings
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
per
share
|
|
|
224,489 |
|
|
|
304,640 |
|
|
|
225,842 |
|
|
|
305,677 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
earnings per share
|
|
$ |
0.45 |
|
|
$ |
0.33 |
|
|
$ |
1.28 |
|
|
$ |
1.05 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted
earnings per share
|
|
$ |
0.44 |
|
|
$ |
0.32 |
|
|
$ |
1.26 |
|
|
$ |
1.03 |
|
4.
|
Stock-Based
Compensation
|
Equity Incentive Plans
The
Company has two equity incentive plans under which the Company may grant
incentive stock options, nonstatutory stock options, stock appreciation rights,
restricted stock, restricted stock units, performances shares and performance
units. Under the plans (the 2005 Equity Incentive Plan and the 2001
Nonstatutory Stock Option Plan), the Company may grant awards to employees,
executive officers, directors and consultants who provide services to the
Company. To date, the Company has only granted nonstatutory stock
options, restricted stock and restricted stock units from these
plans. At March 30, 2008, 15.2 million shares were available for
grant under the plans. Options generally become exercisable over a
five-year period (generally 10% every six months). Options granted
prior to January 11, 2005 expire ten years after the date of grant; options
granted after January 11, 2005 expire seven years after the date of the
grant. The Company’s restricted stock awards generally vest annually
over a five year period (20% per year) based upon continued employment with the
Company.
In
addition, the Company has an Employee Stock Purchase Plan (“ESPP”) that is
currently available to employees only. The ESPP permits eligible employees to
purchase common stock through payroll deductions at 85% of the fair market value
of the common stock at the end of each six-month offering period. The
offering periods commence on approximately May 1 and November 1 of each
year. At March 30, 2008, 0.5 million shares were available for
issuance under the ESPP.
Accounting for Stock-Based
Compensation
The
Company accounts for stock-based compensation arrangements in accordance with
the provisions of Financial Accounting Standards Board Statement (FASB) No.
123(R) (SFAS 123R), “Share-Based Payment.” Under SFAS 123R, compensation cost is
calculated on the date of grant using the fair value of stock options as
determined using the Black-Scholes valuation model. The Company
amortizes the compensation cost straight-line over the vesting period, which is
generally five years. The Black-Scholes valuation model requires the
Company to estimate key assumptions such as expected term, volatility and
forfeiture rates to determine the fair value of a stock option. The estimate of
these key assumptions is based on historical information and judgment regarding
market factors and trends.
As of
March 30, 2008, there was approximately $161.7 million of total
unrecognized stock-based compensation cost related to share-based payments
granted under the Company’s stock-based compensation plans that will be
recognized over a period of approximately five years. Future grants
will add to this total, whereas quarterly amortization and the vesting of the
existing grants will reduce this total.
The table
below outlines the effects of total stock-based compensation for the three and
nine months ended March 30, 2008 and April 1, 2007:
In
thousands, except per share amounts
|
Three
Months Ended
|
|
Nine
Months Ended
|
|
|
March
30,
|
|
April
1,
|
|
March
30,
|
|
April
1,
|
|
|
2008
|
|
2007
|
|
2008
|
|
2007
|
|
|
|
|
|
|
|
|
|
|
Stock-based
compensation
|
$ 15,031
|
(1)
|
$ 18,335
|
(1)
|
$ 43,657
|
(1)
|
$ 53,182
|
(1)
|
|
|
|
|
|
|
|
|
|
Tax
effect of stock-based compensation
|
(4,284)
|
|
(5,134)
|
|
(12,731)
|
|
(15,474)
|
|
Net
effect on net income
|
$ 10,747
|
|
$ 13,201
|
|
$ 30,926
|
|
$ 37,708
|
|
|
|
|
|
|
|
|
|
|
Effect
on earnings per share
|
|
|
|
|
|
|
|
|
Basic
|
$ 0.05
|
|
$ 0.04
|
|
$ 0.14
|
|
$ 0.13
|
|
Diluted
|
$ 0.05
|
|
$ 0.04
|
|
$ 0.14
|
|
$ 0.12
|
|
|
|
|
|
|
|
|
|
|
Shares
used in basic EPS
|
222,046
|
|
299,455
|
|
221,979
|
|
300,212
|
|
Shares
used in diluted EPS
|
224,489
|
|
304,640
|
|
225,842
|
|
305,677
|
|
(1)
Stock-based compensation includes the effects of stock options, restricted
stock, restricted stock units and the ESPP.
The
Company issues new shares of common stock upon exercise of stock options. For
the three and nine months ended March 30, 2008, 0.8 million and 3.2 million
stock options, respectively, were exercised for a gain (aggregate intrinsic
value) of $10.9 million and $52.8 million, respectively, determined as of the
date of option exercise.
Stock
Options
The
following table summarizes stock option activity and related information under
all stock option plans:
|
|
|
|
|
Weighted-
|
|
|
|
Stock
|
|
|
Average
|
|
|
|
Options
|
|
|
Exercise
|
|
|
|
Outstanding
|
|
|
Price
|
|
Outstanding
options, July 1, 2007
|
|
|
30,207,097 |
|
|
$ |
33.87 |
|
|
|
|
|
|
|
|
|
|
Granted
|
|
|
65,000 |
|
|
|
35.84 |
|
Forfeited
and expired
|
|
|
(527,780 |
) |
|
|
41.46 |
|
Exercised
|
|
|
(3,225,608 |
) |
|
|
15.33 |
|
Outstanding
options, March 30, 2008
|
|
|
26,518,709 |
|
|
$ |
35.97 |
|
Vested
and expected to vest as of March 30, 2008
|
|
|
25,855,459 |
|
|
$ |
35.96 |
|
|
|
|
|
|
|
|
|
|
Options
vested and exercisable at:
|
|
|
|
|
|
|
|
|
March
30, 2008
|
|
|
23,957,914 |
|
|
$ |
35.93 |
|
Restricted
Stock
The
following table summarizes the Company’s restricted stock and restricted stock
unit activity under all equity award plans:
|
|
Restricted
Awards Outstanding
|
|
|
Weighted-Average
Grant-Date Fair Value
|
|
Nonvested
at July 1, 2007
|
|
|
4,182,321 |
|
|
$ |
34.45 |
|
|
|
|
|
|
|
|
|
|
Granted
|
|
|
1,726,618 |
|
|
|
34.11 |
|
Vested
|
|
|
(877,576 |
) |
|
|
34.92 |
|
Forfeited
|
|
|
(133,353 |
) |
|
|
34.44 |
|
Nonvested
at March 30, 2008
|
|
|
4,898,010 |
|
|
$ |
34.25 |
|
|
|
|
|
|
|
|
|
|
5. Comprehensive
Income
Accumulated
other comprehensive income consists of unrealized gains or losses on
available-for-sale securities. The components of comprehensive income
were as follows:
|
|
Three
Months Ended
|
|
|
Nine
Months Ended
|
|
In
thousands
|
|
March
30,
|
|
|
April
1,
|
|
|
March
30,
|
|
|
April
1,
|
|
|
|
2008
|
|
|
2007
|
|
|
2008
|
|
|
2007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net
income
|
|
$ |
99,234 |
|
|
$ |
98,550 |
|
|
$ |
284,464 |
|
|
$ |
315,951 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Changes
in unrealized gains or losses
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
on
available-for-sale securities
|
|
|
2,389 |
|
|
|
877 |
|
|
|
5,004 |
|
|
|
4,409 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
comprehensive income
|
|
$ |
101,623 |
|
|
$ |
99,427 |
|
|
$ |
289,468 |
|
|
$ |
320,360 |
|
6. Convertible
Senior Notes
During
the fourth quarter of fiscal year 2007, the Company issued $1.0 billion
aggregate principal amount of its 3.00% Convertible Senior Notes due May 1, 2027
(the “2027A notes”) and $700 million aggregate principal amount of its 3.125%
Convertible Senior Notes due May 1, 2027 (the “2027B notes” and, together with
the 2027A notes, the “Notes”) to qualified institutional buyers pursuant to Rule
144A under the Securities Act of 1933. The Notes are the Company’s
unsubordinated, unsecured obligations and rank equal in right of payment with
all of the Company’s other existing and future unsubordinated, unsecured
obligations; the Notes rank junior in right of payment to any of the Companys
secured obligations to the extent of the value of the collateral securing such
obligations; and the Notes are effectively subordinated in right of payment to
all existing and future indebtedness and liabilities of our
subsidiaries. There is not a sinking fund in connection with the
Notes. The Company received net proceeds from the issuance of the
Notes of $1,678.0 million after the deduction of issuance costs of $22.0
million. The Company used the entire net proceeds of the offering to
fund a portion of its repurchase of $3.0 billion of its common stock pursuant to
an accelerated stock repurchase transaction it entered into with an affiliate of
the initial purchaser of the Notes simultaneously with the offering of the
Notes. The debt issuance costs are recorded in other non-current
assets and are being amortized to interest expense on a straight-line basis over
the earliest redemption date of November 1, 2010 (3.5 years for the 2027B notes)
and May 1, 2014 (7 years for the 2027A notes). Interest is payable
semiannually in arrears on May 1 and November 1, beginning on November 1,
2007.
Upon
conversion of the Notes, the Company will pay the holder cash equal to the
lesser of the aggregate principal amount and the conversion value of the Notes
being converted. If the conversion value exceeds $1,000, the Company must also
deliver cash or common stock or a combination of cash and common stock, at the
Company’s option, for the conversion value in excess of $1,000 (“conversion
spread”). The conversion value of the Notes is determined based on a daily
conversion value calculated on a proportionate basis for each trading day in a
20 trading day conversion reference period. For purposes of
calculating earnings per share, there would be no adjustment to the shares in
the earnings per share calculation for the cash settled portion of the Notes, as
that portion of the debt instrument will always be settled in cash. The
conversion spread will be included in the shares for the calculation of diluted
earnings per share to the extent the conversion price is dilutive under the
treasury stock method. At March 30, 2008, no shares related to the
Notes were included in the computation of diluted earnings per
share. As of the date hereof, the conversion rate of the 2027A notes
is 20.3133 shares of common stock per $1,000 principal amount of the 2027A
notes, subject to adjustment upon the occurrence of certain events as described
in the Indenture for the 2027A notes (including the payment of
dividends). As of the date hereof, the conversion rate of the 2027B
notes is 20.1242 shares of common stock per $1,000 principal amount of the 2027B
notes, subject to adjustment upon the occurrence of certain events as described
in the Indenture for the 2027B notes (including the payment of
dividends). The payment of the dividend approved by the Company’s
Board of Directors in April 2008 will cause a further minor adjustment in the
conversion rate of the Notes. The Notes will bear contingent interest equal to
0.25% commencing May 1, 2014 for the 2027A notes and November 1, 2010 for the
2027B notes under certain circumstances. The Company may redeem the 2027A notes
for cash at any time on or after May 1, 2014, and holders may require the
Company to repurchase the 2027A notes for cash on specified dates or upon a
fundamental change. The Company may redeem the 2027B notes for cash
at any time on or after November 1, 2010, and holders may require the Company to
repurchase the 2027B notes for cash on specified dates or upon a fundamental
change.
7. Product
Warranty and Indemnification
The
Company’s warranty policy provides for the replacement of defective
parts. In certain large contracts, the Company has agreed to
negotiate in good faith a product warranty in the event that an epidemic failure
of its parts were to take place. To date there have been no such
occurrences. Warranty expense historically has been
negligible.
The
Company provides a limited indemnification for certain customers against
intellectual property infringement claims related to the Company's products. In
certain cases, there are limits on and exceptions to the Company's potential
liability for indemnification relating to intellectual property infringement
claims. To date, the Company has not incurred any significant
indemnification expenses relating to intellectual property infringement
claims. The Company cannot estimate the amount of potential future
payments, if any, that the Company might be required to make as a result of
these agreements, and accordingly, the Company has not accrued any amounts for
its indemnification obligations.
8. Recent
Accounting Pronouncements
In August
2007, the Financial Accounting Standards Board (“FASB”) exposed for comment FASB
Staff Position (“FSP”) APB 14-a; a clarification on the accounting for
convertible debt instruments that may be settled in cash (including partial cash
settlement) upon conversion. The FASB is considering a requirement to
allocate a portion of the debt to the embedded conversion feature, thereby
creating an original issue discount on the carrying value of the debt portion of
the instrument. This original issue discount would subsequently be amortized as
interest expense over the term of the instrument, resulting in an increase to
the Company’s reported interest expense. If implemented, this non-cash charge
could have an impact of roughly $0.03 per share on the Company’s quarterly
earnings per share. In March 2008, the FASB voted to ballot FSP APB
14-a, for final issuance. The proposed guidance will become effective for the
Company beginning the first quarter of fiscal year 2010.
9. Accounting
Changes
Effective
at the beginning of the first quarter of fiscal year 2008, the Company adopted
Emerging Issues Task Force (“EITF”) No. 06-2, “Accounting for Sabbatical, Leave
and Other Similar Benefits Pursuant to FASB Statement No. 43” (“EITF
06-2”). EITF 06-2 requires companies to accrue the cost of such
compensated absences over the requisite service period. The Company’s
Sabbatical Program provides for six weeks of paid leave for salaried (exempt)
employees in the United States upon the completion of five years of service and
four weeks of paid leave for nonexempt employees in the United States upon the
completion of five years of service. Prior to the adoption of EITF 06-2, the
Company accounted for the sabbatical program only after the completion of the
five years by the eligible employees because none of the benefits vested or
accreted to the employee until completion of the full five years of service. The
Company adopted EITF 06-2 through a cumulative-effect adjustment, resulting in
an additional long-term liability of $8.2 million and an increase to accumulated
deficit of $5.2 million net of taxes at the beginning of
the first quarter of fiscal year 2008.
The
Company also adopted FASB Interpretation No. 48, “Accounting for Uncertainty in
Income Taxes—an interpretation of FASB Statement No. 109” (“FIN 48”), and
related guidance in the first quarter of 2008. See “Note 10: Income Taxes” for
further discussion.
The
implementation of EITF 06-2 and FIN 48 did not have a material impact on the
results of operations in the current quarter.
10. Income
Taxes
In June
2006, the FASB issued Interpretation No. 48, “Accounting for Uncertainty in
Income Taxes—an Interpretation of FASB Statement No. 109” (“FIN 48”) to create a
single model to address accounting for uncertainty in tax
positions. FIN 48 clarifies the accounting for income taxes by
describing a minimum recognition threshold a tax position is required to meet
before being recognized in the financial statements. Under FIN 48, the Company
must recognize the tax benefit from an uncertain tax position only if it is more
likely than not that the tax position will be sustained on examination by the
taxing authorities, based on the technical merits of the position. The tax
benefits recognized in the financial statements from such a position are
measured based on the largest benefit that has a greater than fifty percent
likelihood of being realized upon ultimate resolution. FIN 48 was adopted by the
Company effective July 2, 2007. The cumulative effect of the change
in accounting principle as a result of the Company’s reassessment of its tax
positions in accordance with FIN 48 was recorded as a decrease of $1.6 million
to accumulated deficit and a decrease in income taxes payable of $1.6 million as
of July 2, 2007.
After
adoption of FIN 48 at July 2, 2007, the Company had $57.9 million of
unrecognized tax benefits which, if recognized, would favorably impact its
effective income tax rate in future periods. As of March 30, 2008,
the Company had $59.6 million of unrecognized tax benefits.
The
Company’s policy is to recognize interest and/or penalties related to income tax
matters in income tax expense. Included in the liability for unrecognized tax
benefits is $8.2 million accrued for interest, net of federal tax benefits, and
$0 accrued for penalties at March 30, 2008.
During
the third quarter ended March 30, 2008, the Company filed its US Federal and
state income tax returns for fiscal 2007. As a result, the Company
recorded in its third quarter a related tax benefit totaling $2.1 million to
adjust for certain estimates included in its fiscal 2007 income tax provision as
compared to the amounts actually filed in its fiscal 2007 income tax
returns.
During
the first quarter ended September 30, 2007, the Company and the California
Franchise Tax Board settled certain tax matters, primarily related to the
research and development tax credit, related to the examination of fiscal years
2000 through 2004. Upon settlement, the Company recognized a tax
benefit during the quarter from the recognition of $1.6 million of unrecorded
tax benefits associated with the research and development credit for those
fiscal years.
During
the quarter ended September 30, 2007, the Company received a Notice of
Deficiency from the Internal Revenue Service (IRS) related to export tax
benefits the Company claimed as its extraterritorial income (ETI) exclusion
under the Internal Revenue Code. The IRS seeks to recover in full the
Company’s ETI benefit claimed on its tax returns for fiscal years 2002 through
2006 totaling $56.5 million plus accrued interest. The Company
disputes the proposed adjustments and intends to pursue the matter through
applicable IRS and judicial procedures as appropriate. It is reasonably possible
that this matter may be resolved within the next twelve months and that the
related unrecognized tax benefits for this tax position may change from those
recorded as liabilities for uncertain tax positions in our financial
statements. However, based on the current status of this matter, it
is not possible to estimate the effect of such changes, if any, to previously
unrecognized tax benefits and there can be no assurance that the resolution of
this matter will not have a material effect on the Company’s financial position
and/or results of operations of future periods.
11.
Contingencies
Litigation
The
Company is subject to various legal proceedings and claims that arise in the
ordinary course of business on a wide range of matters, including, among others,
patent suits and employment claims. The Company does not believe that
any such current suits will have a material impact on its business or financial
condition. However, current lawsuits and any future lawsuits will
divert resources and could result in the payment of substantial
damages.
The Company previously disclosed that the Securities and Exchange
Commission (“SEC”) and the United States Justice Department had initiated
informal inquiries into the Company’s stock option granting
practices. On October 1, 2007, the Company received notice from the
SEC that the investigation concerning the Company’s historical stock option
granting practices had been completed and that no enforcement action was
recommended. The Company has not received any further requests from
the Department of Justice. The Company also disclosed that on
September 5, 2006, it received an Information Document Request from the Internal
Revenue Service (“IRS”) concerning its stock option grants and grant
practices. The Company provided the IRS with information in response
to that and subsequent requests. The Company was also contacted by
the California Franchise Tax Board regarding the IRS’s inquiries, but was
informed in March 2008 that the Board would not be proceeding with any further
actions.
Certain
current and former directors and officers of the Company have been named as
defendants in two shareholder derivative actions filed in the United States
District Court for the Northern District of California, which have been
consolidated under the caption In re Linear Technology Corporation
Shareholder Derivative Litigation (the “Federal Action”), in three
consolidated shareholder derivative actions filed in the Superior Court for
Santa Clara County, California, also captioned In re Linear Technology Corporation
Shareholder Derivative Litigation (the “California State Action”), and in
a shareholder derivative action filed in Delaware Chancery Court, captioned
Weiss v. Swanson (the
“Delaware Action”). The Company has been named in each of these
Actions as a nominal defendant against which no recovery is
sought. The Company has engaged outside counsel to represent it in
the government inquiries and pending lawsuits.
In the
Federal Action, the plaintiffs alleged that the individual defendants breached
their fiduciary duties to the Company in connection with the alleged backdating
of stock option grants during the period from 1995 through 2002, and asserted
derivative claims against the individual defendants based on alleged violations
of Section 10(b) of the Securities Exchange Act of 1934 (“Exchange Act”),
and Rule 10b-5 promulgated thereunder. The plaintiffs sought to recover
unspecified money damages, disgorgement of profits and benefits, equitable
relief and attorneys’ fees and costs. The Company moved to dismiss
the Federal Action on the ground that the plaintiffs had not made a
pre-litigation demand on the Company’s Board of Directors and had not
demonstrated that such a demand would have been futile. The
individual defendants joined in that motion, and also moved to dismiss the
complaint for failure to state a claim against each of them. On
December 7, 2006, the District Court granted the Company’s motion; the Court did
not address the individual defendants’ motion. The plaintiffs filed
an amended complaint on January 5, 2007 asserting derivative claims against the
individual defendants for alleged violations of Sections 10(b), 14(a), and 20(a)
of the Exchange Act, and Rules 10b-5 and 14a-9 promulgated thereunder.
Pursuant to the parties’ stipulation, on February 14, 2007, the District Court
entered an order staying the Federal Action in favor of permitting the
California State Action to proceed.
In the
California State Action, the plaintiffs initially asserted claims against the
individual defendants for breach of fiduciary duty and aiding and abetting one
another’s alleged breaches of duty in connection with the alleged backdating of
stock option grants during the period from 1995 through 2002. The
plaintiffs also alleged that certain defendants were unjustly enriched, that
defendants wasted corporate assets, and that the officer defendants engaged in
insider trading in violation of California law. The plaintiffs sought
to recover unspecified money damages, disgorgement of profits and benefits,
restitution, rescission of option contracts, imposition of a constructive trust
over option contracts, and attorneys’ fees and costs. On October 2,
2006, the Company moved to stay the California State Action in favor of the
Federal Action. The individual defendants joined in that motion and
demurred to the California State Action on the basis that the complaint failed
to state a cause of action as to each of them. Following the stay of
the Federal Action, the Company withdrew the Motion to Stay Proceedings and
demurred to the complaint on the ground that the plaintiffs had not demonstrated
that a pre-suit demand would have been futile. The individual
defendants joined in that demurrer. Following a hearing on July 13,
2007, the Court sustained the Company’s demurrer, and granted the plaintiffs
leave to amend the complaint. The Court did not address the
individual defendants’ demurrer.
On August
13, 2007, the plaintiffs in the California State Action filed an amended
complaint, asserting claims against the individual defendants for breach of
fiduciary duty and aiding and abetting one another’s alleged breaches of duty in
connection with the grant of allegedly “spring-loaded” and “bullet-dodged” stock
options during the period from 1995 through 2005. The amended
complaint also alleged that the individual defendants were unjustly enriched,
and engaged in insider trading in violation of the California Corporations Code,
and that the director defendants wasted corporate assets. The amended
complaint sought recovery from the individual defendants of unspecified damages,
disgorgement of profits and benefits, restitution, rescission of option
contracts and imposition of a constructive trust over executory option
contracts, in addition to attorneys’ fees and costs. On September 12,
2007, the Company filed a demurrer to the amended complaint on the ground that
the plaintiffs had failed to make a pre-suit demand or to demonstrate that
demand would have been futile. The individual defendants filed a
demurrer to the amended complaint on the grounds that it failed to state a cause
of action as to each of them. The parties stipulated to stay the
California State Action pending the outcome of the hearing on the motion to
dismiss the Delaware Action. As discussed below, the motion to
dismiss the Delaware action was recently denied. Accordingly, on
April 21, 2008, the parties established a briefing schedule for a motion by
defendants to continue the stay of the California State Action until the
conclusion of the Delaware Action.
In the
Delaware Action, filed on March 23, 2007, the plaintiff alleges that the
defendant directors breached their duty by granting “spring-loaded” and
“bullet-dodged” stock options to certain of the Company’s officers and directors
during the period from 1996 through 2005. The plaintiff also asserts
claims for unjust enrichment against those defendants who received the
challenged option grants. The plaintiff seeks to recover unspecified money
damages, disgorgement of profits and benefits, restitution, rescission of
certain defendants’ option contracts, imposition of a constructive trust over
the option contracts, and attorneys’ fees and costs. The defendants
moved to dismiss the Delaware Action on May 25, 2007. Rather than
respond to the defendants’ motions, the plaintiff filed an amended complaint on
August 10, 2007, making substantially the same allegations as those in the
original complaint. On September 19, 2007, the Company and the
individual defendants filed a Motion to Dismiss the amended complaint on the
grounds that the plaintiff had failed to make a pre-suit demand on the Board or
to plead facts demonstrating that demand would have been futile, and that the
amended complaint failed to state a claim against each of the individual
defendants. The Court denied the defendants’ motion to dismiss the
amended complaint on March 7, 2008. Linear answered the amended
complaint on April 7, 2008. No trial date has been
set.
The
Company has reviewed its historical option-granting practices and option grants
with the assistance of outside counsel and an independent forensic accounting
firm. The primary scope of the review covered the period from
calendar year 1995 through 2006. Based on the findings of the review,
the Company concluded that there was no need to restate any previously filed
financial statements. The review found no evidence of fraud or
misconduct of any kind in the Company’s practices in granting of stock options,
and as mentioned above, on October 1, 2007, the Company received notice from the
SEC that its investigation concerning the Company’s historical stock option
grant practices had been completed and that no enforcement action was
recommended.
Critical
Accounting Estimates
The
Company’s financial statements have been prepared in accordance with accounting
principles generally accepted in the United States, which require it to make
estimates and judgments that significantly affect the reported amounts of
assets, liabilities, revenues and expenses and related disclosure of contingent
assets and liabilities. The Company regularly evaluates these estimates,
including those related to stock-based compensation, inventory valuation,
revenue recognition and income taxes. These estimates are based on historical
experience and on assumptions that are believed by management to be reasonable
under the circumstances. Actual results may differ from these estimates, which
may impact the carrying values of assets and liabilities.
The
Company believes the following critical accounting policies affect the more
significant judgments and estimates used in the preparation of the Company’s
consolidated financial statements.
Stock-Based
Compensation
Beginning
in fiscal year 2006, the Company accounts for stock-based compensation
arrangements in accordance with the provisions of Statement of Financial
Accounting Standards 123(R) (“SFAS 123R”). Under SFAS 123R, stock option cost is
calculated on the date of grant using the Black-Scholes valuation model. The
compensation cost is then amortized straight-line over the vesting
period. The Company uses the Black-Scholes valuation model to
determine the fair value of its stock options at the date of
grant. The Black-Scholes valuation model requires the Company to
estimate key assumptions such as expected term, volatility, dividend yields and
risk free interest rates that determine the stock options fair value. If actual
results are not consistent with the Company’s assumptions and judgments used in
estimating the key assumptions, the Company may be required to increase or
decrease compensation expense or income tax expense, which could be material to
its results of operations. In addition, SFAS 123R requires
forfeitures to be estimated at the time of grant. In subsequent periods, if
actual forfeitures differ from the estimate, the forfeiture rate may be
revised. The Company estimates forfeitures based on its historical
activity, as it believes these forfeiture rates to be indicative of its expected
forfeiture rate.
Inventory
Valuation
The
Company values inventories at the lower of cost or market. The
Company records charges to write down inventories for unsalable, excess or
obsolete raw materials, work-in-process and finished goods. Newly
introduced parts are generally not valued until success in the market place has
been determined by a consistent pattern of sales and backlog among other
factors. The Company arrives at the estimate for newly released parts
by analyzing sales and customer backlog against ending inventory on
hand. The Company reviews the assumptions on a quarterly basis and
makes decisions with regard to inventory valuation based on the current business
climate. In addition to write-downs based on newly introduced parts,
judgmental assessments are calculated for the remaining inventory based on
salability, obsolescence, historical experience and current business
conditions. If actual market conditions are less favorable than those
projected by management, additional inventory write-downs may be required that
could adversely affect operating results. If actual market conditions are more
favorable, the Company may have higher gross margins when products are
sold. Sales to date of such products have not had a significant
impact on gross margin.
Revenue
Recognition
The
Company recognizes revenues when the earnings process is complete, when
persuasive evidence of an arrangement exists, the product has been delivered,
the price is fixed and determinable and collection is reasonably
assured. The Company recognizes approximately 16% of net revenues
from domestic distributors that are recognized under agreements which provide
for certain sales price rebates and limited product return
privileges. Given the uncertainties associated with the levels of
pricing rebates, the ultimate sales price on domestic distributor sales
transactions is not fixed or determinable until domestic distributors sell the
merchandise to the end-user. At the time of shipment to domestic
distributors, the Company records a trade receivable and deferred revenue at the
distributor purchasing price since there is a legally enforceable obligation
from the distributor to pay for the products delivered. The Company
relieves inventory as title has passed to the distributor and recognizes
deferred cost of sales in the same amount. “Deferred income on shipments to
distributors” represents the difference between deferred revenue and
deferred cost of sales and is recognized as a current liability until such time
as the distributor confirms a final sale to its end customer. At
March 30, 2008 the Company had approximately $46.1 million of deferred revenue
and $8.4 million of deferred cost of sales recognized as $37.7 million of
“Deferred income on shipment to distributors”. At July 1, 2007 the Company
had approximately $49.0 million of deferred revenue and $9.1 million of deferred
cost of sales recognized as $39.9 million of “Deferred income on shipment to
distributors”. To the extent the Company were to have a significant
reduction in distributor price or grant significant price rebates, there could
be a material impact on the ultimate revenue and gross profit recognized. These
price rebates that have been remitted back to distributors have ranged from $1.5
million to $3.1 million per quarter.
The
Company’s sales to international distributors are made under agreements which
permit limited stock return privileges but not sales price
rebates. Revenue on these sales is recognized upon shipment at which
time title passes. The Company has reserves to cover expected product
returns. If product returns for a particular fiscal period exceed or
are below expectations, the Company may determine that additional or less sales
return allowances are required to properly reflect its estimated exposure for
product returns. Generally, changes to sales return allowances have
not had a significant impact on operating margin.
Income
Taxes
The
Company must make certain estimates and judgments in determining income tax
expense for financial statement purposes. These estimates and judgments occur in
the calculation of tax credits, tax benefits and deductions and in the
calculation of certain tax assets and liabilities, which arise from differences
in the timing of recognition of revenue and expense for tax and financial
statement purposes. Significant changes to these estimates may result in an
increase or decrease to the tax provision in a subsequent period.
The
calculation of the Company’s tax liabilities involves dealing with uncertainties
in the application of complex tax regulations. The Company recognizes
liabilities for anticipated tax audit issues in the U.S. and other tax
jurisdictions based on its estimate of whether, and the extent to which,
additional tax payments are probable. If the Company determines that payment of
these amounts is unnecessary, in concert with a review of its total tax
liabilities, it may reverse the liability and recognize a tax benefit during the
period in which it determines that the liability is no longer
necessary. The Company will also record an additional charge to its
provision for taxes in the period in which it determines that the recorded tax
liability is less than it expects the ultimate assessment to be. For a
discussion of current tax matters, see “Note 10. Income Taxes” in
Part I, Item 1 of this Form 10-Q.
Results
of Operations
Results
of Operations
The table
below summarizes the income statement items for the three and nine months ended
March 30, 2008 and April 1, 2007 as a percentage of total revenue and provides
the percentage change in absolute dollars of such items comparing the interim
period ended March 30, 2008 to the corresponding period from the prior fiscal
year:
|
Three
Months Ended
|
|
Nine
Months Ended
|
|
|
March
30,
|
|
April
1,
|
|
Increase/
|
|
March
30,
|
|
April
1,
|
|
Increase/
|
|
|
2008
|
|
2007
|
|
(Decrease)
|
|
2008
|
|
2007
|
|
(Decrease)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues
|
100.0%
|
|
100.0%
|
|
17%
|
|
100.0%
|
|
100.0%
|
|
7%
|
|
Cost
of sales
|
22.5
|
|
22.2
|
|
18
|
|
22.7
|
|
22.1
|
|
9
|
|
Gross
profit
|
77.5
|
|
77.8
|
|
16
|
|
77.3
|
|
77.9
|
|
6
|
|
Expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
Research
and development
|
16.6
|
|
17.8
|
|
9
|
|
16.7
|
|
16.8
|
|
6
|
|
Selling,
general and
|
|
|
|
|
|
|
|
|
|
|
|
|
administrative
|
11.9
|
|
12.8
|
|
8
|
|
11.7
|
|
12.4
|
|
1
|
|
|
28.5
|
|
30.6
|
|
9
|
|
28.4
|
|
29.2
|
|
4
|
|
Operating
income
|
49.0
|
|
47.2
|
|
21
|
|
48.9
|
|
48.7
|
|
7
|
|
Interest
expense
|
(4.8)
|
|
(0.2)
|
|
3321
|
|
(5.0)
|
|
(0.1)
|
|
3,241
|
|
Interest
income
|
2.5
|
|
6.7
|
|
(57)
|
|
2.4
|
|
6.1
|
|
(58)
|
|
Income
before
|
|
|
|
|
|
|
|
|
|
|
|
|
income taxes
|
46.7%
|
|
53.7%
|
|
1
|
|
46.3%
|
|
54.7%
|
|
(10)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effective
tax rates
|
28.5%
|
|
28.0%
|
|
|
|
29.2%
|
|
29.1%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenue
for the quarter ended March 30, 2008 was $297.9 million, an increase of $42.9
million or 17% over revenue of $255.0 million for the same quarter of the
previous fiscal year. The increase in revenue was primarily due to
the Company selling more units into the industrial and communication
end-markets, partially offset by a reduction in its consumer end-market
sales. The average selling price (“ASP”) decreased from $1.67 per
unit in the third quarter of fiscal year 2007 to $1.57 per unit in the third
quarter of fiscal year 2008. The decrease in the Company’s ASP is
primarily due to the change in sales mix and to a lesser extent the Company
lowering its selling price on certain products that have reached significant
volume levels. Geographically, international revenues were $209.9
million or 70% of revenues, an increase of $42.5 million or 25% as compared to
international revenues of $167.4 million or 66% of revenues for the same quarter
of the previous fiscal year. The increase in international revenues
as a percentage of revenues is primarily due to certain domestic OEM customers
migrating their manufacturing to international subcontractors. Internationally,
revenues to Rest of the World (“ROW”), which is primarily Asia excluding Japan,
represented $110.0 million or 37% of revenues, while sales to Europe and Japan
were $58.3 million or 19% of revenues and $41.6 million or 14% of revenues,
respectively. Domestic revenues were $88.0 million or 30% of revenues
in the third quarter of fiscal year 2008, an increase of $0.4 million, from
$87.6 million or 34% of revenues in the same period in fiscal year
2007.
Revenue
for the nine months ended March 30, 2008 was $868.1 million, an increase of
$53.2 million or 7% over revenue of $815.0 million for the same period of the
previous fiscal year. The increase in revenue for the nine-month
period ended March 30, 2008 was due to increases in all end-markets, primarily
industrial, automotive and military/space end-markets. The ASP for
the first nine months of fiscal year 2008 decreased to $1.54 per unit from $1.61
per unit in the same period of fiscal year 2007. The decrease in the
Company’s ASP is due to similar factors as in the three-month period ended March
30, 2008. Geographically, international revenues were $611.9 million
or 70% of revenues, an increase of $55.0 million over international revenues of
$556.9 million or 68% of revenues for the same period of the previous fiscal
year. The increase in international revenues as a percentage of
revenues is primarily due to certain domestic OEM customers migrating their
manufacturing to international subcontractors. Internationally,
revenues to ROW, represented $343.0 million or 39% of revenues, while sales to
Europe and Japan were $155.8 million or 18% of revenues and $113.1 million or
13% of revenues, respectively. Domestic revenues were $256.2 million
or 30% of revenues in the first nine month period of fiscal year 2008, a
decrease of $1.8 million, compared to $258.0 million or 32% of revenues in the
same period in fiscal year 2007.
During
the first quarter of fiscal year 2008, the Company had one set of significant
stock option grants that became fully vested after five years and one
significant set of restricted stock grants that became fully vested after three
years. As a result, the Company had lower stock-based compensation
charges in cost of sales; research and development; and selling, general and
administrative expense when compared to the third quarter and the first nine
month period of fiscal year 2007. Future stock grants will add to
stock-based compensation charges whereas completion of vesting of previous
grants will decrease stock-based compensation charges. Unvested stock
option and restricted stock grants generally vest straight-line over a five year
period.
Gross
profit was $230.9 million and $670.9 million for the third quarter and the first
nine-month period of fiscal year 2008, an increase of $32.5 million and $36.1
million, respectively, from the corresponding periods of fiscal year
2007. Gross profit as a percentage of revenues decreased to 77.5% in
third quarter of fiscal year 2008 as compared to 77.8% of revenues for the same
period in the previous fiscal year. Gross profit as a percentage of
revenue decreased to 77.3% for the first nine months of fiscal year 2008 as
compared to 77.9% of revenues for the same period in the pervious fiscal
year. The decrease in gross profit as a percentage of revenues for
the three- and nine-month periods ended March 30, 2008 was primarily due to
increases in employee profit sharing as well as a decrease in ASP, both of
which were largely offset by improved factory efficiencies on higher
sales volume as well as a decrease in costs related to stock-based compensation
expense.
Research
and development (“R&D”) expenses for the quarter ended March 30, 2008 were
$49.6 million, an increase of $4.2 million or 9% over R&D expenses of $45.4
million for the same period in the previous fiscal year. The increase
in R&D was due to a $2.9 million increase in compensation costs related to
employee headcount and annual salary increases. Since the Company had
better operating results as compared to third quarter of fiscal year 2007,
R&D employee profit sharing grew $1.9 million. In addition, the Company had
a $0.6 million increase in other R&D related expenses such as mask costs and
small tool charges. Offsetting these increases to R&D was a $1.2
million decrease in stock-based compensation expense.
R&D
expenses for the nine months ended March 30, 2008 were $145.2 million, an
increase of $8.4 million or 6% over R&D expenses of $136.8 million for the
same period in the previous fiscal year. The increase in R&D was
due to an $8.5 million increase in compensation costs related to employee
headcount and annual salary increases. The increase in R&D
expense was also due to a $3.3 million increase in employee profit
sharing. Offsetting these increases was a $3.5 million decrease in
stock-based compensation expense.
Selling,
general and administrative expenses (“SG&A”) for the quarter ended March 30,
2008 were $35.4 million, an increase of $2.6 million or 8% over SG&A expense
of $32.8 million for the same period in the previous fiscal year. The
increase in SG&A was due to a $2.4 million increase in compensation costs
related to employee headcount and annual salary increases. The
increase in SG&A expense was also due to a $1.4 million increase in employee
profit sharing. Offsetting these increases was a $1.2 million
decrease in stock-based compensation expense.
SG&A
for the nine months ended March 30, 2008 were $101.8 million, an increase of
$1.0 million over SG&A expenses of $100.8 million for the same period in the
previous fiscal year. The increase in SG&A was due to a $4.6
million increase in compensation costs related to employee headcount and annual
salary increases. The increase of SG&A expense was also due to a
$2.5 million increase in employee profit sharing. Offsetting these
increases was a $3.4 million decrease in stock-based compensation expense and a
$2.7 million decrease in other SG&A related expenses, primarily legal
costs.
Interest
expense was $14.4 million and $43.4 million for the third quarter and the first
nine-month period of fiscal year 2008, an increase of $14.0 million and $42.1
million, respectively, over the corresponding periods of fiscal year
2007. The increase in interest expense was due to the Company’s
issuance of $1.7 billion Convertible Senior Notes during the fourth quarter of
fiscal year 2007 bearing interest at 3.0% and 3.125%. Interest expense for the
third quarter and the first nine month period of fiscal year 2008 is primarily
comprised of convertible debt interest, amortization of the convertible debt
discount and amortization of issuance costs.
Interest
income was $7.3 million and $21.0 million for the third quarter and the first
nine month period of fiscal year 2008, a decrease of $9.7 million and $28.8
million, respectively, from the corresponding periods of fiscal year
2007. Interest income decreased due to the Company’s lower average
cash and short-term investment balances as the Company used $1.3 billion of its
cash to fund a portion of its $3.0 billion accelerated share repurchase (“ASR”)
transaction during the fourth quarter of fiscal year 2007.
The
Company’s effective tax rate for the third quarter of fiscal year 2008 was 28.5%
as compared to 28% in the same quarter of fiscal year 2007. The Company’s
effective tax rate for the nine months ended March 30, 2008 was 29.2% as
compared to 29.1% in the corresponding period of fiscal year
2007. The increase in the effective tax rates for these periods was
primarily due to lower R&D tax credits as this tax benefit expired as of
December 31, 2007. The Company believes that the R&D tax credit
will be restored by legislation retroactive to the beginning of calendar year
2008, but there can be no assurance that this will happen. In
addition, the effective tax rate is higher due to lower tax-exempt interest
income and the expiration of the ETI export tax benefit. These
decreases are partially offset by an increase in foreign earnings in lower tax
jurisdictions, higher domestic production tax benefits and the impact of
quarterly discrete adjustments.
The
Company’s effective tax rate is lower than the federal statutory rate of 35% as
a result of lower tax rates on the earnings of its wholly-owned foreign
subsidiaries, principally in Singapore and Malaysia. The Company has
a partial tax holiday through July 2015 in Malaysia and a partial tax holiday in
Singapore through August 2011. In addition, the Company receives tax benefits
from non-taxable interest income and domestic manufacturing
credits.
Net
income was $99.2 million for the third quarter, an increase of $0.7 million from
the same period in the previous fiscal year. Net income was $284.5
million the first nine month period of fiscal year 2008, a decrease of $31.5
million from the same period in fiscal year 2007. However, third
quarter and year to date diluted earnings per share (“EPS”) increased by $0.12
and $0.23 per share, respectively, over the corresponding periods of fiscal year
2007. This anomaly occurred due to the Company entering into a $3.0
billion ASR transaction during the fourth quarter of fiscal year
2007. The ASR transaction was funded by $1.3 billion of the Company’s
own cash and $1.7 billion of convertible debt. As a result, the
Company’s third quarter and year to date results have both a decrease in
interest income and an increase in interest expense when compared to the
corresponding periods of the previous fiscal year. However, shares
used in the calculation of diluted EPS decreased by 80.2 million or 26%, and by
79.8 million or 26% from the third quarter and the first nine month period of
fiscal year 2007 primarily due to the ASR. Consequently, the ASR transaction has
been accretive to EPS, as the impact of the reduced shares was greater than the
reduction in net income from higher interest expense and lower interest
income.
Factors
Affecting Future Operating Results
Except
for historical information contained herein, the matters set forth in this Form
10-Q, including the statements in the following paragraphs, are forward-looking
statements that are dependent on certain risks and uncertainties, including such
factors, among others, as the timing, volume and pricing of new orders received
and shipped during the quarter, the timely introduction of new processes and
products, general conditions in the world economy and financial markets and
other factors described below, in Item 1A herein and in the Company’s Form 10-K
for the fiscal year ended July 1, 2007.
Revenues
for the three months ended March 30, 2008 grew 3% sequentially over the second
quarter of fiscal year 2008 and met the mid-point of the Company’s guidance
stated at the beginning of the period. This
marks the fourth consecutive quarter that the Company has sequentially grown
revenues, operating margin and EPS. These improvements have occurred
in spite of difficult economic times. This performance is indicative of the
success of the Company’s strategy of diversification both geographically and by
end-market. Looking ahead, given the concerns about economic
difficulties particularly in the USA, forecasting future results continues to be
a challenge. June should be a growth quarter as we had a positive book-to-bill
ratio in the March quarter and we would expect the June quarter to continue to
have strength in many of the Company’s end-markets. However, the overriding
general economic conditions merit concern. Consequently, the Company presently
estimates that revenues and income before taxes will grow 1% to 5% sequentially
from the March quarter.
Estimates
of future performance are uncertain, and past performance of the Company may not
be a good indicator of future performance due to factors affecting the Company,
its competitors, the semiconductor industry and the overall
economy. The semiconductor industry is characterized by rapid
technological change, price erosion, cyclical market patterns, periodic
oversupply conditions, occasional shortages of materials, capacity constraints,
variations in manufacturing efficiencies and significant expenditures for
capital equipment and product development. Furthermore, new product
introductions and patent protection of existing products, as well as exposure
related to patent infringement suits if brought against the Company, are factors
that can influence future sales growth and sustained
profitability. The Company’s headquarters and a portion of its
manufacturing facilities and research and development activities and certain
other critical business operations are located near major earthquake fault lines
in California, consequently, the Company could be adversely affected in the
event of a major earthquake.
Although
the Company believes that it has the product lines, manufacturing facilities and
technical and financial resources for its current operations, sales and
profitability could be significantly affected by factors described above and
other factors. Additionally, the Company’s common stock could be
subject to significant price volatility should sales and/or earnings fail to
meet expectations of the investment community. Furthermore, stocks of high
technology companies are subject to extreme price and volume fluctuations that
are often unrelated or disproportionate to the operating performance of these
companies.
Liquidity
and Capital Resources
At March
30, 2008, cash, cash equivalents and short-term investments totaled $907.9
million and working capital was $1,003.9 million. Accounts receivable
totaled $150.2 million at the end of the third quarter of fiscal year 2008, an
increase of $19.7 million from the end of the fourth quarter of fiscal year
2007. The increase is primarily due to higher
shipments. Prepaid expenses and other current assets totaled $16.4
million, an increase of $5.3 million primarily due to the increase in the
Company’s interest income receivable balance.
Accrued
payroll and related benefits of $46.5 million at the end of the third quarter of
fiscal year 2008 decreased $8.0 million from the fourth quarter of fiscal year
2007. The decrease is primarily due to the payment of profit
sharing. The Company accrues for profit sharing on a quarterly basis
while distributing payouts to employees on a semi-annual basis during the first
and third quarters. Income taxes payable totaled $20.2 million at the
end of the third quarter of fiscal year 2008, a decrease of $25.1 million from
the fourth quarter of fiscal year 2007 primarily due to the reclassification of
$59.6 million in unrecognized tax benefits to other long-term liabilities as a
result of the implementation of FIN 48 during the first quarter of fiscal year
2008. This effect was partially offset by the net of quarterly tax
payments and the Company’s tax provision. Other accrued liabilities
of $40.6 million increased $11.6 million over the fourth quarter of fiscal year
2007 primarily due to accrued interest on the Company’s convertible senior
notes. The Company makes semi-annual interest payments during the
second and fourth quarters.
Deferred
tax liabilities totaled $35.3 million, an increase of $22.4 million primarily
due to an increase in deferred taxes related to interest deductions for the
Company’s convertible senior debt. Other long-term liabilities of
$98.3 million increased $64.3 million over the fourth quarter of fiscal year
2007 primarily due to the unrecognized tax benefit reclassification of $59.6
million noted above and due to the implementation of EITF 06-2, which resulted
in a $9.3 million increase for accrued sabbaticals.
During
the first nine months of fiscal year 2008, the Company generated $399.8 million
of cash from operating activities, $52.7 million in proceeds from common stock
issued under employee stock plans and $10.7 million from excess tax benefits
received on the exercise of stock options.
During
the first nine months of fiscal year 2008, significant cash expenditures
included $304.0 million for net purchases of short-term investments; payments of
$129.0 million for cash dividends to stockholders, representing $0.57 per share;
$50.7 million for repurchases of the Company’s common stock; payments of $15.7
million for capital assets; and $1.0 million for a long-term investment in a
privately held company. In April 2008, the Company’s Board of
Directors declared a cash dividend of $0.21 per share. The $0.21 per
share dividend will be paid on May 28, 2008 to shareholders of record on May 16,
2008. The payment of future dividends will be based on the Company’s
financial performance.
Historically,
the Company has satisfied its liquidity needs through cash generated from
operations. Given its financial condition and historical operating
performance, the Company believes that current capital resources and cash
generated from operating activities will be sufficient to meet its liquidity and
capital expenditures requirements for the foreseeable future.
Off
Balance-Sheet Arrangements
As of
March 30, 2008, the Company had no off-balance sheet financing
arrangements.
Contractual
Obligations
In April
2007, the Company issued $1.0 billion principal amount of 3.0% debentures due
May 1, 2027 and $0.7 billion principal amount of 3.125% debentures due May 1,
2027. The Company will pay cash interest at an annual rate of 3.0%
and 3.125%, respectively, payable semiannually on November 1 and May 1 of each
year, beginning November 1, 2007. See Note 6 to the condensed consolidated
financial statements, included in Part 1. “Financial Information,” for
additional information about the debentures.
Item
3. Quantitative
and Qualitative Disclosures About Market Risk
For
additional quantitative and qualitative disclosures about market risk affecting
the Company, see item 7A of the Company’s Form 10-K for the fiscal year ended
July 1, 2007. There have been no material changes in the market risk
affecting the Company since the filing of the Company’s Form 10-K for fiscal
year 2007. At March 30, 2008, the Company’s cash and cash equivalents
consisted primarily of bank deposits, commercial paper and money market funds.
The Company’s short-term investments consisted of municipal bonds, federal
agency bonds, commercial paper, and related securities. The Company did not hold
any derivative financial instruments. The Company’s interest income is sensitive
to changes in the general level of interest rates. In this regard, changes in
interest rates can affect the interest earned on cash and cash equivalents and
short-term investments.
The
Company’s revenues outside the United States are transacted in U.S. dollars;
accordingly the Company’s revenues are not impacted by foreign currency rate
changes. To date, fluctuations in foreign currency exchange rates
have not had a material impact on the results of operations.
Item
4.
Controls and Procedures
(a)Evaluation of Disclosure Controls
and Procedures.
The
Company’s management, with the participation of its Chief Executive Officer and
Chief Financial Officer, evaluated the effectiveness of the Company’s disclosure
controls and procedures as of the end of the period covered by this Quarterly
Report on Form 10-Q. For purposes of this section, the term disclosure controls and
procedures means controls and other procedures of an issuer that are
designed to ensure that information required to be disclosed by the issuer in
the reports that it files or submits under the Securities Exchange Act of 1934
(15 U.S.C. 78a et seq.)
is recorded, processed, summarized and reported within the time periods
specified in the Commission's rules and forms. Disclosure controls
and procedures include, without limitation, controls and procedures designed to
ensure that information required to be disclosed by an issuer in the reports
that it files or submits under the Securities Exchange Act of 1934 is
accumulated and communicated to the issuer's management, including its principal
executive and principal financial officers, or persons performing similar
functions, as appropriate to allow timely decisions regarding required
disclosure.
The
Company’s management evaluated, with the participation of its Chief Executive
Officer and Chief Financial Officer, the effectiveness of the Company’s
disclosure controls and procedures for the quarter ended March 30,
2008. Based on this evaluation, the Company’s Chief Executive Officer
and Chief Financial Officer have concluded that the Company’s disclosure
controls and procedures are effective to ensure that information it is required
to disclose in reports that it files or submits under the Securities Exchange
Act of 1934 is accumulated and communicated to the Company’s management,
including its principal executive and principal financial officers, as
appropriate to allow timely decisions regarding required disclosure, and that
such information is recorded, processed, summarized and reported within the time
periods specified in Securities and Exchange Commission rules and
forms.
(b)Changes in Internal Control over
Financial Reporting.
No change
in the Company’s internal control over financial reporting (as defined in
Rules 13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934)
occurred during the quarter ended March 30, 2008 that has materially affected,
or is reasonably likely to materially affect, the Company’s internal control
over financial reporting.
PART
II.
|
OTHER
INFORMATION
|
Item
1.
|
Legal
Proceedings
|
The
Company is subject to various legal proceedings and claims that arise in the
ordinary course of business on a wide range of matters, including, among others,
patent suits and employment claims. The Company does not believe that
any such current suits will have a material impact on its business or financial
condition. However, current lawsuits and any future lawsuits will
divert resources and could result in the payment of substantial
damages.
The
Company previously disclosed that the Securities and Exchange Commission (“SEC”)
and the United States Justice Department had initiated informal inquiries into
the Company’s stock option granting practices. On October 1, 2007,
the Company received notice from the SEC that the investigation concerning the
Company’s historical stock option granting practices had been completed and that
no enforcement action was recommended. The Company has not received
any further requests from the Department of Justice. The Company also
disclosed that on September 5, 2006, it received an Information Document Request
from the Internal Revenue Service (“IRS”) concerning its stock option grants and
grant practices. The Company provided the IRS with information in
response to that and subsequent requests. The Company was also
contacted by the California Franchise Tax Board regarding the IRS’s inquiries,
but was informed in March 2008 that the Board would not be proceeding with any
further actions.
Certain
current and former directors and officers of the Company have been named as
defendants in two shareholder derivative actions filed in the United States
District Court for the Northern District of California, which have been
consolidated under the caption In re Linear Technology Corporation
Shareholder Derivative Litigation (the “Federal Action”), in three
consolidated shareholder derivative actions filed in the Superior Court for
Santa Clara County, California, also captioned In re Linear Technology Corporation
Shareholder Derivative Litigation (the “California State Action”), and in
a shareholder derivative action filed in Delaware Chancery Court, captioned
Weiss v. Swanson (the
“Delaware Action”). The Company has been named in each of these
Actions as a nominal defendant against which no recovery is
sought. The Company has engaged outside counsel to represent it in
the government inquiries and pending lawsuits.
In the
Federal Action, the plaintiffs alleged that the individual defendants breached
their fiduciary duties to the Company in connection with the alleged backdating
of stock option grants during the period from 1995 through 2002, and asserted
derivative claims against the individual defendants based on alleged violations
of Section 10(b) of the Securities Exchange Act of 1934 (“Exchange Act”),
and Rule 10b-5 promulgated thereunder. The plaintiffs sought to recover
unspecified money damages, disgorgement of profits and benefits, equitable
relief and attorneys’ fees and costs. The Company moved to dismiss
the Federal Action on the ground that the plaintiffs had not made a
pre-litigation demand on the Company’s Board of Directors and had not
demonstrated that such a demand would have been futile. The
individual defendants joined in that motion, and also moved to dismiss the
complaint for failure to state a claim against each of them. On
December 7, 2006, the District Court granted the Company’s motion; the Court did
not address the individual defendants’ motion. The plaintiffs filed
an amended complaint on January 5, 2007 asserting derivative claims against the
individual defendants for alleged violations of Sections 10(b), 14(a), and 20(a)
of the Exchange Act, and Rules 10b-5 and 14a-9 promulgated thereunder.
Pursuant to the parties’ stipulation, on February 14, 2007, the District Court
entered an order staying the Federal Action in favor of permitting the
California State Action to proceed.
In the
California State Action, the plaintiffs initially asserted claims against the
individual defendants for breach of fiduciary duty and aiding and abetting one
another’s alleged breaches of duty in connection with the alleged backdating of
stock option grants during the period from 1995 through 2002. The
plaintiffs also alleged that certain defendants were unjustly enriched, that
defendants wasted corporate assets, and that the officer defendants engaged in
insider trading in violation of California law. The plaintiffs sought
to recover unspecified money damages, disgorgement of profits and benefits,
restitution, rescission of option contracts, imposition of a constructive trust
over option contracts, and attorneys’ fees and costs. On October 2,
2006, the Company moved to stay the California State Action in favor of the
Federal Action. The individual defendants joined in that motion and
demurred to the California State Action on the basis that the complaint failed
to state a cause of action as to each of them. Following the stay of
the Federal Action, the Company withdrew the Motion to Stay Proceedings and
demurred to the complaint on the ground that the plaintiffs had not demonstrated
that a pre-suit demand would have been futile. The individual
defendants joined in that demurrer. Following a hearing on July 13,
2007, the Court sustained the Company’s demurrer, and granted the plaintiffs
leave to amend the complaint. The Court did not address the
individual defendants’ demurrer.
On August
13, 2007, the plaintiffs in the California State Action filed an amended
complaint, asserting claims against the individual defendants for breach of
fiduciary duty and aiding and abetting one another’s alleged breaches of duty in
connection with the grant of allegedly “spring-loaded” and “bullet-dodged” stock
options during the period from 1995 through 2005. The amended
complaint also alleged that the individual defendants were unjustly enriched,
and engaged in insider trading in violation of the California Corporations Code,
and that the director defendants wasted corporate assets. The amended
complaint sought recovery from the individual defendants of unspecified damages,
disgorgement of profits and benefits, restitution, rescission of option
contracts and imposition of a constructive trust over executory option
contracts, in addition to attorneys’ fees and costs. On September 12,
2007, the Company filed a demurrer to the amended complaint on the ground that
the plaintiffs had failed to make a pre-suit demand or to demonstrate that
demand would have been futile. The individual defendants filed a
demurrer to the amended complaint on the grounds that it failed to state a cause
of action as to each of them. The parties stipulated to stay the
California State Action pending the outcome of the hearing on the motion to
dismiss the Delaware Action. As discussed below, the motion to
dismiss the Delaware action was recently denied. Accordingly, on
April 21, 2008, the parties established a briefing schedule for a motion by
defendants to continue the stay of the California State Action until the
conclusion of the Delaware Action.
In the
Delaware Action, filed on March 23, 2007, the plaintiff alleges that the
defendant directors breached their duty by granting “spring-loaded” and
“bullet-dodged” stock options to certain of the Company’s officers and directors
during the period from 1996 through 2005. The plaintiff also asserts
claims for unjust enrichment against those defendants who received the
challenged option grants. The plaintiff seeks to recover unspecified money
damages, disgorgement of profits and benefits, restitution, rescission of
certain defendants’ option contracts, imposition of a constructive trust over
the option contracts, and attorneys’ fees and costs. The defendants
moved to dismiss the Delaware Action on May 25, 2007. Rather than
respond to the defendants’ motions, the plaintiff filed an amended complaint on
August 10, 2007, making substantially the same allegations as those in the
original complaint. On September 19, 2007, the Company and the
individual defendants filed a Motion to Dismiss the amended complaint on the
grounds that the plaintiff had failed to make a pre-suit demand on the Board or
to plead facts demonstrating that demand would have been futile, and that the
amended complaint failed to state a claim against each of the individual
defendants. The Court denied the defendants’ motion to dismiss the
amended complaint on March 7, 2008. Linear answered the amended
complaint on April 7, 2008. No trial date has been
set.
The
Company has reviewed its historical option-granting practices and option grants
with the assistance of outside counsel and an independent forensic accounting
firm. The primary scope of the review covered the period from
calendar year 1995 through 2006. Based on the findings of the review,
the Company concluded that there was no need to restate any previously filed
financial statements. The review found no evidence of fraud or
misconduct of any kind in the Company’s practices in granting of stock options,
and as mentioned above, on October 1, 2007, the Company received notice from the
SEC that its investigation concerning the Company’s historical stock option
grant practices had been completed and that no enforcement action was
recommended.
A description of the risk factors
associated with the Company’s business is set forth below. In addition to the
risk factors discussed below, see “Factors Affecting Future Operating Results”
included in “Management's Discussion and Analysis” for further discussion of
other risks and uncertainties that may affect the Company.
Downturns
in the business cycle could adversely affect our revenues and
profitability.
The
semiconductor market has historically been cyclical and subject to significant
economic downturns at various times. The cyclical nature of the
semiconductor industry may cause us to experience substantial period-to-period
fluctuations in our results of operations. The growth rate of the
global economy is one of the factors affecting demand for semiconductor
components. Many factors could adversely affect regional or global
economic growth including increased price inflation for goods, services or
materials, rising interest rates in the United States and the rest of the world,
a significant act of terrorism which disrupts global trade or consumer
confidence, geopolitical tensions including war and civil unrest, reduced levels
of economic activity, or disruptions of international
transportation.
Typically,
our ability to meet our revenue goals and projections is dependent to a large
extent on the orders we receive from our customers within the period and by our
ability to match inventory and current production mix with the product mix
required to fulfill orders on hand and orders received within a period for
delivery in that period. Because of this complexity in our business,
no assurance can be given that we will achieve a match of inventory on hand,
production units, and shippable orders sufficient to realize quarterly or annual
revenue and net income goals.
Volatility
in customer demand in the semiconductor industry could affect future levels of
sales and profitability and limit our ability to predict such
levels.
Historically,
we have maintained low lead times, which has enabled customers to place orders
close to their true needs for product. In defining our financial goals and
projections, we consider inventory on hand, backlog, production cycles and
expected order patterns from customers. If our estimates in these
areas become inaccurate, we may not be able to meet our revenue goals and
projections. In addition, some customers require us to manufacture
product and have it available for shipment, even though the customer is
unwilling to make a binding commitment to purchase all, or even some, of the
product. As a result, in any quarterly fiscal period we are subject
to the risk of cancellation of orders leading to a fall-off of sales and
backlog. Further, those orders may be for products that meet the
customer’s unique requirements so that those cancelled orders would, in
addition, result in an inventory of unsaleable products, and thus potential
inventory write-offs. We routinely estimate inventory reserves
required for such products, but actual results may differ from these reserve
estimates.
We
generate revenue from thousands of customers worldwide and our revenues are
diversified by end-market and geographical region. However, the loss
of, or a significant reduction of purchases by a portion of our customer base
could adversely affect our results of operations. We can lose a
customer due to a change in the customer’s design or purchasing
practices. In addition, the timing of customers’ inventory
adjustments may adversely affect our results of operations.
We
may be unsuccessful in developing and selling new products required to maintain
or expand our business.
The
markets for our products depend on continued demand for our products in the
communications, industrial, computer, high-end consumer and automotive
end-markets. The semiconductor industry is characterized by rapid technological
change, variations in manufacturing efficiencies of new products, and
significant expenditures for capital equipment and product
development. New product introductions are a critical factor for
future sales growth and sustained profitability and can present significant
business challenges because product development commitments and expenditures
must be made well in advance of the related revenues. The success of
a new product depends on a variety of factors including accurate forecasts of
long-term market demand and future technological developments, timely and
efficient completion of process design and development, timely and efficient
implementation of manufacturing and assembly processes, product performance,
quality and reliability of the product, and effective marketing, sales and
service.
Although
we believe that the high performance segment of the linear integrated circuit
market is generally less affected by price erosion or by significant
expenditures for capital equipment and product development than other
semiconductor market sectors, future operating results may reflect substantial
period-to-period fluctuations due to these or other factors.
Our
manufacturing operations may be interrupted or suffer yield
problems.
We rely
on our internal manufacturing facilities located in California and Washington to
fabricate most of our wafers, although we depend on outside silicon foundries
for a small portion (less than 5%) of our wafer fabrication. We could be
adversely affected in the event of a major earthquake, which could cause
temporary loss of capacity, loss of raw materials, and damage to manufacturing
equipment. Additionally, we rely on our internal and external
assembly and testing facilities located in Singapore and Malaysia. We
are subject to economic and political risks inherent to international
operations, including changes in local governmental policies, currency
fluctuations, transportation delays and the imposition of export controls or
increased import tariffs. We could be adversely affected if any such changes are
applicable to our foreign operations.
Our
manufacturing yields are a function of product design and process technology,
both of which are developed by us. The manufacture and design of
integrated circuits is highly complex. We may experience
manufacturing problems in achieving acceptable yields or experience product
delivery delays in the future as a result of, among other things, capacity
constraints, equipment malfunctioning, construction delays, upgrading or
expanding existing facilities or changing our process technologies, any of which
could result in a loss of future revenues or increases in fixed
costs. To the extent we do not achieve acceptable manufacturing
yields or there are delays in wafer fabrication, our results of operations could
be adversely affected. In addition, operating expenses related to
increases in production capacity may adversely affect our operating results if
revenues do not increase proportionately.
Our
dependence on third party foundries and other manufacturing subcontractors may
cause delays beyond our control in delivering our products to our
customers.
A portion
of our wafers (approximately 20%) are processed offshore by independent assembly
subcontractors located in Malaysia and Thailand. These subcontractors
separate wafers into individual circuits and assemble them into various finished
package types. Reliability problems experienced by our assemblers
could cause problems in delivery and quality, resulting in potential product
liability to us. We could also be adversely affected by political
disorders, labor disruptions, and natural disasters in these
locations.
We are
dependent on outside silicon foundries for a small portion (less than 5%) of our
wafer fabrication. As a result, we cannot directly control delivery
schedules for these products, which could lead to product shortages, quality
assurance problems and increases in the cost of our products. We may
experience delays in delivering our products to our customers. If
these foundries are unable or unwilling to produce adequate supplies of
processed wafers conforming to our quality standards, our business and
relationships with our customers for the limited quantities of products produced
by these foundries could be adversely affected. Finding alternate
sources of supply or initiating internal wafer processing for these products may
not be economically feasible. In addition, the manufacture of our
products is a highly complex and precise process, requiring production in a
highly controlled environment. Changes in manufacturing processes or
the inadvertent use of defective or contaminated materials by a third party
foundry could adversely affect the foundry’s ability to achieve acceptable
manufacturing yields and product reliability.
We
rely on third party suppliers for materials, supplies, and subcontract services
that may not have adequate capacity to meet our product delivery
requirements.
The
semiconductor industry has experienced a very large expansion of fabrication
capacity and production worldwide over time. As a result of increasing demand
from semiconductor and other manufacturers, availability of certain basic
materials and supplies, such as chemicals, gases, polysilicon, silicon wafers,
ultra-pure metals, lead frames and molding compounds, and of subcontract
services, like epitaxial growth, ion implantation and assembly of integrated
circuits into packages, have from time to time, over the past several years,
been in short supply and could come into short supply again if overall industry
demand continues to increase in the future. In addition, from time to time
natural disasters can lead to a shortage of some of the above materials due to
disruption of the manufacturer’s production. We do not have long-term
agreements providing for all of these materials, supplies, and services, and
shortages could occur as a result of capacity limitations or production
constraints on suppliers that could have a materially adverse effect on our
ability to achieve our planned production.
A number
of our products use components that are purchased from third
parties. Supplies of these components may not be sufficient to meet
all customer requested delivery dates for products containing the components,
which could adversely affect future sales and earnings. Additionally,
significant fluctuations in the purchase price for these components could affect
gross margins for the products involved. Suppliers could also
discontinue the manufacture of such purchased products or could have quality
problems that could affect our ability to meet customer
commitments. In addition, suppliers of semiconductor manufacturing
equipment are sometimes unable to deliver test and/or fabrication equipment to a
schedule or equipment performance specification that meets our
requirements. Delays in delivery of equipment needed for growth could
adversely affect our ability to achieve our manufacturing and revenue plans in
the future.
We
are exposed to business, economic, political and other risks through our
significant worldwide operations.
For the
nine months ended March 30, 2008, 70% of our revenues were derived from
customers in international markets. Also, we have test and assembly facilities
outside the United States in Singapore and Malaysia. Accordingly, we are subject
to the economic and political risks inherent in international operations and
their impact on the United States economy in general, including the risks
associated with ongoing uncertainties and political and economic instability in
many countries around the world as well as the economic disruption from acts of
terrorism, and the response to them by the United States and its
allies.
We
are a party to private litigation and governmental investigations related to our
historical stock option granting practices, an unfavorable outcome in which
could have a material adverse effect on our financial results for a particular
period or the trading price for our securities.
Several
lawsuits have been filed against current and former directors and officers
relating to our historical stock option practices. We are named as a
nominal defendant in those lawsuits. These actions are in the
preliminary stages, and their ultimate outcome could have a material adverse
effect on our results of operations or cash flows for a particular period or the
trading price for our securities. Litigation is time-consuming,
expensive and disruptive to our normal business operations, and outcomes are
difficult to predict. The defense of these lawsuits has resulted and
will continue to result in significant legal expenditures and diversion of our
management’s time and attention from business operations. In
addition, we have entered into indemnification agreements with our current and
former directors and officers, under which we are required to indemnify those
persons against expenses, including attorneys’ fees, judgments, fines and
settlements, payable by them in connection with this litigation, subject to
applicable law. If we were required to pay any amounts to satisfy a
judgment or in settlement of any of these claims, these amounts may not be
covered by insurance.
As
disclosed previously, we have also been the subject of informal investigations
and inquiries by the Securities and Exchange Commission, the Department of
Justice and the Internal Revenue Service. The SEC has informed us
that its investigation concerning our historical stock option grant practices
has been completed and that no enforcement action has been
recommended. We have not been subsequently contacted by the
DOJ. All agencies could seek additional information or documents from
us in the future. We could also in the future become the subject of
additional private or government actions regarding these matters.
For a
further discussion on legal matters see “Legal Proceedings” in Part 2,
Item 1 of this Form 10-Q.
We
may be unable to adequately protect our proprietary rights, which may impact our
ability to compete effectively.
Our
success depends in part on our proprietary technology. While we attempt to
protect our proprietary technology through patents, copyrights and trade secret
protection, we believe that our success also depends on increasing our
technological expertise, continuing our development of new products and
providing comprehensive support and service to our
customers. However, we may be unable to protect our technology in all
instances, or our competitors may develop similar or more competitive technology
independently. We currently hold a number of United States and
foreign patents and pending patent applications. However, other
parties may challenge or attempt to invalidate or circumvent any patents the
United States or foreign governments issue to us or these governments may fail
to issue patents for pending applications. In addition, the rights
granted or anticipated under any of these patents or pending patent applications
may be narrower than we expect or, in fact provide no competitive
advantages. Furthermore, effective patent, trademark, copyright,
maskwork and trade secret protection may be unavailable, limited or not applied
for in certain foreign countries. We may incur significant legal costs to
protect our intellectual property.
We also
seek to protect our proprietary technology, including technology that may not be
patented or patentable, in part by confidentiality agreements and, if
applicable, inventors’ rights agreements with our collaborators, advisors,
employees and consultants. We cannot assure you that these agreements
will always be undertaken or will not be breached or that we will have adequate
remedies for any breach.
We have
received, and may receive in the future, notices of claims of infringement and
misappropriation of other parties’ proprietary rights. In the event
of an adverse decision in a patent, trademark, copyright, maskwork or trade
secret action, we could be required to withdraw the product or products found to
be infringing from the market or redesign products offered for sale or under
development. Whether or not these infringement claims are
successfully asserted, we would likely incur significant costs and diversion of
our resources with respect to the defense of these claims. In the
event of an adverse outcome in any litigation, we may be required to pay
substantial damages, including enhanced damages for willful infringement, and
incur significant attorneys’ fees, as well as indemnify customers for damages
they might suffer if the products they purchase from us infringe intellectual
property rights of others. We could also be required to stop our
manufacture, use, sale or importation of infringing products, expend significant
resources to develop or acquire non-infringing technology, discontinue the use
of some processes, or obtain licenses to intellectual property rights covering
products and technology that we may, or have been found to, infringe or
misappropriate such intellectual property rights.
Our
products may contain defects that could affect our results of
operations.
Our
products may contain undetected errors or defects. Such problems may
cause delays in product introductions and shipments, result in increased costs
and diversion of development resources, cause us to incur increased charges due
to obsolete or unusable inventory, require design modifications, or decrease
market acceptance or customer satisfaction with these products, which could
result in product returns. In addition, we may not find defects or
failures in our products until after commencement of commercial shipments, which
may result in loss or delay in market acceptance and could significantly harm
our operating results. Our current or potential customers also might
seek to recover from us any losses resulting from defects or failures in our
products; further, such claims might be significantly higher than the revenues
and profits we receive from our products involved as we are usually a component
supplier with limited value content relative to the value of a complete system
or sub-system. Liability claims could require us to spend significant
time and money in litigation or to pay significant damages for which we may have
insufficient insurance coverage. Any of these claims, whether or not
successful, could seriously damage our reputation and business.
If
we fail to attract and retain qualified personnel, our business may be
harmed.
Our
performance is substantially dependent on the performance of our executive
officers and key employees. The loss of the services of key officers,
technical personnel or other key employees could harm the
business. Our success depends on our ability to identify, hire,
train, develop and retain highly qualified technical and managerial
personnel. Failure to attract and retain the necessary technical and
managerial personnel could harm us.
We
may not be able to compete successfully in markets within the semiconductor
industry in the future.
We
compete in the high performance segment of the linear market. Our competitors
include among others, Analog Devices, Inc., Intersil, Maxim Integrated Products,
Inc., National Semiconductor Corporation and Texas Instruments, Inc. Competition
among manufacturers of linear integrated circuits is intense, and certain of our
competitors may have significantly greater financial, technical, manufacturing
and marketing resources than us. The principal elements of
competition include product performance, functional value, quality and
reliability, technical service and support, price, diversity of product line and
delivery capabilities. We believe we compete favorably with respect to these
factors, although we may be at a disadvantage in comparison to larger companies
with broader product lines and greater technical service and support
capabilities.
Environmental
liabilities could force us to expend significant capital and incur substantial
costs.
Federal,
state and local regulations impose various environmental controls on the
storage, use, discharge and disposal of certain chemicals and gases used in
semiconductor processing. Our facilities have been designed to comply
with these regulations, and we believe that our activities conform to present
environmental regulations. Increasing public attention has, however,
been focused on the environmental impact of electronics manufacturing
operations. While we to date have not experienced any materially
adverse business effects from environmental regulations, there can be no
assurance that changes in such regulations will not require us to acquire costly
remediation equipment or to incur substantial expenses to comply with such
regulations. Any failure by us to control the storage, use or
disposal of, or adequately restrict the discharge of hazardous substances could
subject us to significant liabilities.
Our
financial results may be adversely affected by increased tax rates and exposure
to additional tax liabilities.
As a
global company, our effective tax rate is highly dependent upon the geographic
composition of worldwide earnings and tax regulations governing each
region. We are subject to income taxes in both the United States and
various foreign jurisdictions, and significant judgment is required to determine
worldwide tax liabilities. Our effective tax rate as well as the
actual tax ultimately payable could be adversely affected by changes in the
split of earnings between countries with differing statutory tax rates, in the
valuation of deferred tax assets, in tax laws or by material audit assessments,
which could affect our profitability. In addition, the amount of
income taxes we pay is subject to ongoing audits in various jurisdictions, and a
material assessment by a governing tax authority could affect our
profitability.
We
are leveraged, and our debt obligations may affect our business, operating
results and financial condition.
In April
2007, we issued $1.0 billion aggregate principal amount of our 3.00% Convertible
Senior Notes due May 1, 2027 and $700 million aggregate principal amount of our
3.125% Convertible Senior Notes due May 1, 2027 (collectively, the
“Notes”). Debt service obligations arising from the Notes could
adversely affect us in a number of ways, including by:
·
|
limiting
our ability to obtain in the future, if needed, financing for working
capital, capital expenditures, debt service requirements or other
corporate purposes;
|
·
|
limiting
our flexibility in implementing our business strategy and in planning for,
or reacting to, changes in our
business;
|
·
|
placing
us at a competitive disadvantage relative to any of our competitors who
have lower levels of debt;
|
·
|
decreasing
our debt ratings and increasing our cost of borrowed
funds;
|
·
|
making
us more vulnerable to a downturn in our business or the economy
generally;
|
·
|
subjecting
us to the risk of being forced to refinance at higher interest rates these
amounts when due; and
|
·
|
requiring
us to use a substantial portion of our cash to pay principal and interest
on our debt instead of contributing those funds to other purposes such as
working capital, capital expenditures or other corporate
purposes.
|
Our
stock price may be volatile.
The
trading price of our common stock may be subject to wide fluctuations. Our stock
price may fluctuate in response to a number of events and factors, such as
quarterly variations in operating results, announcements of technological
innovations or new products by us or our competitors, changes in financial
estimates and recommendations by securities analysts, the operating and stock
price performance of other companies that investors may deem comparable to us,
the hedging of our common stock and other derivative transactions by third
parties, and new reports relating to trends in our markets or general economic
conditions. Additionally, lack of positive performance in our stock
price may adversely affect our ability to retain key employees.
The stock
market in general, and prices for companies in our industry in particular, has
experienced extreme volatility that often has been unrelated to the operating
performance of a particular company. These broad market and industry
fluctuations may adversely affect the price of our common stock, regardless of
our operating performance. As our Notes are convertible into shares
of our common stock, volatility or depressed prices of our common stock could
have a similar effect on the trading price of our Notes. In addition,
to the extent we deliver common stock on conversion of the Notes, the ownership
interests of our existing stockholders may be diluted. Sales in the public
market of common stock issuable upon such conversion could adversely affect
prevailing market prices of our common stock, as could the anticipated
conversion of the Notes.
We
may not have the ability to repurchase the Notes or to pay cash upon their
conversion if and as required by the indentures governing the
Notes.
Holders
of the Notes have the right to require us to repurchase, and we intend to
repurchase, the Notes for cash on specified dates or upon the occurrence of a
fundamental change. However, we may not have sufficient funds to
repurchase the Notes in cash or to make the required repayment at such time or
have the ability to arrange necessary financing on acceptable terms. In
addition, upon conversion of the Notes we will be required to make cash payments
to the holders of the Notes equal to the lesser of the principal amount of the
Notes being converted and the conversion value of those Notes. Such
payments could be significant, and we may not have sufficient funds to make them
at such time.
Our
failure to repurchase the Notes or convert the Notes into cash or a combination
of cash and shares upon exercise of a holder’s conversion right in accordance
with the provisions of the indentures would constitute a default under the
applicable indenture. In addition, a default under either indenture
could lead to a default under existing and future agreements governing our
indebtedness. If, due to a default, the repayment of the related
indebtedness were to be accelerated after any applicable notice or grace
periods, we may not have sufficient funds to repay such indebtedness and the
Notes.
A
fundamental change may also constitute an event of default under, or result in
the acceleration of the maturity of, our then-existing indebtedness. In
addition, our ability to repurchase the Notes in cash or make any other required
payments may be limited by law or the terms of other agreements relating to our
indebtedness outstanding at the time.
The
terms of the Notes and related provisions in the indentures subject noteholders
to risks. Noteholders should be aware of the following risks, in
addition to those described for holders of our common stock:
·
|
We
are not restricted from taking actions or incurring additional debt
(including secured debt) which may affect our ability to make payments
under the Notes;
|
·
|
The
Notes are not secured by any of our assets or those of our subsidiaries
and are effectively subordinated to any secured debt we may
incur. In any liquidation, dissolution, bankruptcy or other
similar proceeding, holders of our secured debt may assert rights against
any assets securing such debt in order to receive full payment of their
debt before those assets may be used to pay the holders of the Notes. In
such an event, we may not have sufficient assets remaining to pay amounts
due on any or all of the Notes. In addition, none of our
subsidiaries have guaranteed our obligations under, or have any obligation
to pay any amounts due on, the Notes. As a result, the Notes
are effectively subordinated to all liabilities of our subsidiaries,
including trade payables;
|
·
|
The
fundamental change provisions in the Notes and the indentures may not
require us to offer to repurchase the Notes in the event of certain
transactions. For example, any leveraged recapitalization,
refinancing, restructuring, or acquisition initiated by us will generally
not constitute a fundamental change requiring us to repurchase the
Notes;
|
·
|
The
liquidity of the trading market in the Notes, and the market price quoted
for these Notes, may be adversely affected by, among other things, changes
in, or other factors affecting, the market prices of our common stock,
changes in the overall market for debt securities, and prevailing interest
rates;
|
·
|
The
conversion rates of the Notes may not adjust for certain events, such as a
third-party tender or exchange offer or an issuance of our common stock
for cash. In addition, adjustments in conversion rates may not
adequately compensate noteholders for any lost value in the Notes as a
result of a particular transaction;
|
·
|
The
Notes may not be rated or may receive a lower rating than anticipated,
which may impact the market price of the Notes and our common
stock. In addition, the sale of the Notes and the shares of
common stock issuable upon conversion of the Notes depends upon the
continued maintenance of a registration statement filed with the SEC
covering the resale of the Notes, or an exemption from the registration
requirements of the Securities Act and any applicable state securities
laws; and,
|
·
|
Noteholders
are not entitled to any rights with respect to our common stock, but if
they subsequently convert their Notes and receive common stock upon such
conversion, they will be subject to all changes affecting the common
stock;
|
The
accounting method for convertible debt securities with net share settlement
features, like the Notes, may be subject to change.
For the
purpose of calculating diluted earnings per share, a convertible debt security
providing for net share settlement of the conversion value and meeting specified
requirements under Emerging Issues Task Force (“EITF”), Issue No. 00-19,
“Accounting for Derivative Financial Instruments Indexed to, and Potentially
Settled in, a Company’s Own Stock,” is accounted for interest expense purposes
similarly to non-convertible debt, with the stated coupon constituting interest
expense and any shares issuable upon conversion of the security being accounted
for under the treasury stock method. The effect of the treasury stock
method is that the shares potentially issuable upon conversion of the Notes are
not included in the calculation of our earnings per share, except to the extent
that the conversion value of the Notes exceeds their principal amount, in which
event the number of shares of our common stock necessary to settle the
conversion are treated as having been issued for earnings per share
purposes.
In August
2007, the Financial Accounting Standards Board (“FASB”) exposed for comment FASB
Staff Position (“FSP”) APB 14-a, a clarification on the accounting for
convertible debt instruments that may be settled in cash (including partial cash
settlement) upon conversion. The FASB is considering a requirement to
allocate a portion of the debt to the embedded conversion feature, thereby
creating an original issue discount on the carrying value of the debt portion of
the instrument. This original issue discount would subsequently be amortized as
interest expense over the term of the instrument, resulting in an increase to
our reported interest expense. This could materially impact our results of
operations and earnings per share. In March 2008, the FASB voted to
ballot FSP APB 14-a, for final issuance. The proposed guidance will become
effective for the Company beginning the first quarter of fiscal year
2010.
Our
certificate of incorporation and by-laws include anti-takeover provisions that
may enable our management to resist an unwelcome takeover attempt by a third
party.
Our
organizational documents and Delaware law contain provisions that might
discourage, delay or prevent a change in control of our company or a change in
our management. Our board of directors may also choose to adopt
further anti-takeover measures without stockholder approval. The
existence and adoption of these provisions could adversely affect the voting
power of holders of common stock and limit the price that investors might be
willing to pay in the future for shares of our common
stock.
Item
2.
|
Unregistered
Sales of Equity Securities and Use of
Proceeds
|
c) Stock
Repurchases
Period
|
Total
Number of Shares Purchased
|
Average
Price Paid per Share
|
Total
Number of Shares Purchased as Part of Publicly Announced Plans or
Programs
|
Maximum
Number of Shares that May Yet be purchased Under the Plans or Programs
(1)
|
Month
#1 (December 31, 2007 – January 27, 2008)
|
3,411,645
|
$35.46
(1)
|
3,411,645
|
17,088,497
|
Month
#2 (January 28, 2008 – February 24, 2008)
|
349,946
|
$32.16
|
349,946
|
16,738,551
|
Month
#3 (February 25, 2008 – March 30, 2008)
|
-
|
-
|
-
|
-
|
Total
|
3,761,591
|
$35.15
|
3,761,591
|
16,738,551
|
(1) On
April 17, 2007 the Company’s Board of Directors authorized a $3.0 billion
accelerated stock repurchase transaction (“ASR”). As part of the ASR,
the Company entered into two $1.5 billion confirmations totaling $3.0 billion
during the fourth quarter of fiscal 2007. Under these confirmations,
the Company provided a financial institution with an up−front payment totaling
$3.0 billion. The number of shares of common stock that were
delivered to the Company for the first confirmation were determined based on the
daily volume weighted average price of the Company’s common stock over an
approximately three-month period that commenced shortly after the issuance of
the Company’s $1.7 billion Convertible Senior Notes in April
2007. Under the terms of the first $1.5 billion confirmation, the
Company received 33.3 million shares of its common stock during the fourth
quarter of fiscal year 2007. The first confirmation ended during the
first quarter of fiscal year 2008 and the Company received an additional 7.7
million shares. Accordingly, under the first confirmation the Company
received a total of 41.0 million shares at an average purchase price of $36.57
per share. Under the terms of the second $1.5 billion confirmation,
the Company received 38.9 million shares of its common stock during the fourth
quarter of fiscal year 2007. The exact number of shares for the
second confirmation was determined by the daily volume weighted average price of
the Company’s common stock (subject to a per share floor price and cap price
resulting in a purchase by the Company under that part of the ASR of no fewer
than approximately 38.9 million shares of common stock and not more than
approximately 42.5 million shares of common stock) over the subsequent
approximately six-month period. The second confirmation ended during the third
quarter of fiscal year 2008 and the Company received an additional 3.4 million
shares. Accordingly, under the second confirmation the Company received a total
of 42.3 million shares at an average purchase price of $35.46 per
share.
(2) On July 25, 2006 the Company’s
Board of Directors authorized the Company to purchase up to 20.0 million shares
of its outstanding common stock in the open market over a two year time period
of which 16.7 million shares still remain for purchase over the next 3 month
period.
Item
3. Defaults Upon Senior Securities
N/A
Item
4. Submission of Matter to a Vote of Security
Holder
N/A
Item
5. Other Information
N/A
Exhibit
|
|
|
Number
|
|
Description
|
|
|
|
|
|
|
Certification
of Principal Executive Officer pursuant to Exchange Act Rules 13a-14(a)
and 15d-14(a), as
|
|
|
|
adopted
pursuant to section 302 of the Sarbanes-Oxley Act of 2002
|
|
|
|
|
|
|
|
Certification
of Principal Financial Officer and Principal Accounting Officer pursuant
to Exchange Act
|
|
|
|
Rules
13a-14(a) and 15d-14(a), as adopted pursuant to section 302 of the
Sarbanes-Oxley Act of 2002
|
|
|
|
|
|
|
|
Certification
of Chief Executive Officer and Chief Financial Officer pursuant to 18
U.S.C. Section 1350 as
|
|
|
|
adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has
duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.
|
LINEAR
TECHNOLOGY CORPORATION
|
|
|
|
DATE:
May 6, 2008
|
BY
|
/s/Paul
Coghlan
|
|
|
Paul
Coghlan
|
|
|
Vice
President, Finance &
|
|
|
Chief
Financial Officer
|
|
|
(Duly
Authorized Officer and
|
|
|
Principal
Financial Officer)
|